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The immune system plays a key role in maintaining human health. Accurately characterizing the 
immune receptors with immune repertoire sequencing (IRseq) provides an essential way for 
understanding the adaptive immune system. Towards this goal, we developed a bioinformatics 
tool, Molecular Identifier Clustering-based IR-Seq (MIDICRS), to quantitatively measure 
immune repertoire. We have demonstrated MIDCIRS’ accuracy, high coverage and wide 
dynamic range, which allow us to analyze various types of immune repertoires. 
 Immune repertoire is continuously shaped by encountered antigens; thus, its components 
reflect an individual’s historical disease status. We applied MIDCIRS to measure the antibody 
repertoire from malaria-experienced individuals and found unexpected mutable capability of 
infants adaptive immune system. We also used MIDCIRS to measure Follicular helper T cells 
(Tfhs) directly obtained from untreated HIV patients’ lymph nodes and found (1) evidence for 
intact antigen-driven clonal expansion of Tfh cells and (2) selective utilization of specific 
complementarity-determining region 3 (CDR3) motifs during chronic HIV infection. Both 




 Bridging the gap between immune receptor sequences and their biological function (i.e. 
antigen specificity) is attractive and useful for directly measuring immune repertoire changes 
with respect to pathogen infection. Using experimentally validated CD8+ TCR sequences with 
their antigen specificity, we developed a computational tool, Linear programming based Motif 
Pick and Enrichment analysis for Tcrs (LiMPETs), to find significant motifs within the TCR 
CDR3 region for determining antigen specificity. We demonstrated LiMPETs’ advantages by 
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Chapter 1: Background 
1.1 IMMUNE SYSTEM 
Our immune system serves as a complex, multifaceted ‘army’ that continuously protects our 
health. It fights against threats from foreign invaders (e.g., bacteria, virus) by killing pathogens 
and infected cells
1
; it also fights against internal threats (e.g., cancerous cells, misfolded proteins) 
by monitoring and destroying damaged cells
2
. Two main immunity strategies comprise the 
human immune system, one is the so-called ‘Innate immunity’, which is responds quickly and 
provides non-specific defense to pathogens; the other is called ‘Adaptive immunity’, which is 
‘learned’ and provides specific defense to certain pathogens. In this thesis, the work summarized 
focuses on Adaptive immunity. 
Innate immunity contains non-specific defense to pathogens, this system includes the skin 
barrier around the body, mucus to trap pathogens, hairs to move mucus trapped pathogens out 
and neutrophils to kill invading bacteria, etc. This system provides immediate protection against 




Compared with innate immunity, the other immune strategy is ‘Adaptive immunity’, 
which has a slower response but is much more complicated and provides long-lasting protection 





1.2 ADAPTIVE IMMUNITY 
Adaptive immunity is also known as ‘acquired immunity’
3
, and as its name implies, this type of 
immune response is acquired and ‘learned’ after the immune system encounters antigens. After 
the immune system first encounters a certain type of pathogen, it will generate immune cells 
specific to this pathogen and ‘memorize’ it. In this way immune system can respond and subdue 
this pathogen very quickly when it comes across the pathogen for a second time. People have 
been making use of this property of the immune system for a long time, i.e., various types of 
vaccines have been developed since 1796
4
 to artificially ‘pre-train’ the adaptive immune system 








 The adaptive immune system contains two types of lymphocytes, which are the T-
lymphocyte and B-lymphocyte. Both of them are initially differentiated from stem cells in bone 
marrow
9
. After their initial differentiation, B cells will continue to mature in bone marrow, while 
T cells will migrate to thymus and mature there
10
. Both of them express cell surface receptors 
which determine their antigen specificity, B cells express B cell receptor (BCR) while T cells 
express T cell receptor (TCR).  B cells can secrete their BCR, which will become a so-called 
‘antibody’ acting to neutralize infected pathogens. In contrast, the TCR remains on T cell surface 
where it is used to contact and recognize other cells, e.g. antigen-presenting cells (APC), and 
become activated. All the BCRs within an individual are termed as the ‘antibody repertoire’, 
while all the TCRs are termed the ‘TCR repertoire’. The recognition of TCR/BCR to antigen can 




Generally speaking, T lymphocytes can be divided into CD8+ T cells and CD4+ T cells, 
depending on which glycoprotein (CD4 or CD8) is expressed on their surface
3
. These 
glycoproteins determine the lymphocytes’ function: CD8+ T cells can recognize peptides 
presented by MHC class I molecules (MHC-I), which are expressed by all nucleated cells, and 
can destroy virus infected cells and tumor cells. CD4+ T cells recognize antigen peptides 
presented by MHC class II molecules (MHC-II), which are expressed by antigen-presenting cells, 
and upon activation they moderate and recruit other immune cells to the antigen source.  
All nucleated cells express MHC-I molecules on their surface and this molecule 
constantly samples peptides from inside the cell
11
. If there are some abnormal changes within the 
cell, e.g., virus infected cells express virus proteins, tumor cells express cancer neoantigens
12
, 
peptides from these proteins are going to be randomly sampled by MHC-I and presented to TCR 
on CD8+ T cells. CD8+ T cells that recognize these peptides as non-self-antigens will be 
activated and release granzymes to trigger abnormal cells apoptosis. This is why CD8+ T cells 
are also called cytotoxic T cells because they can trigger cell apoptosis. 
Compared to CD8+ T cells, CD4+ T cells are much more heterogeneous. CD4+ T cells 
perform supporting or regulation roles in immune response, which are termed ‘cell-mediated 
immunity’. CD4+ T cells that function as supporting roles are generally called helper T cells (Th 
cells). According to their cytokine/transcriptome files/function differences, helper T cells can be 
distinguished into several types, e.g., Th1 cells, Th2 cells and Th17 cells.  These cells can be 
activated through TCR recognizing antigen peptides or by cytokine secreted from other immune 
cells
13
. Activated Th1 cells produce cytokine IFN-γ and IL-2, which activate macrophages and 
CD8+ T cells to induce monocytic inflammation, which kills intracellular bacteria, protozoans 
and viruses. Activated Th2 cells produce IL-13, IL-4,IL-5,IL-25, etc., which induces 
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eosinophilic/basophilic/mast cell inflammation to kill helminths. Activated Th17 cells produce 
IL-17, IL-22 etc, which induce neutrophilic inflammation to kill extracellular bacteria and 
fungi
14
. Another specialized type of helper T cells is follicular helper T cells (Tfh cells), which 
mainly provide help to B cells within secondary lymphoid organs (e.g., lymph node, spleen and 
tonsil), as well as induce and stabilize the formation of germinal center within B cell follicles 
located in secondary lymphoid organs
15
. Finally, regulatory T cells (Tregs
16
) produce IL-10, 
TGF-β, etc., which suppresses immune response and are important for autoimmune diseases. 
1.3 FOUR SOURCES OF T/B RECEPTOR DIVERSITY 
Because of their antigen specificity, one T(B)CR can only recognize a certain antigen (or a few 
antigens, because of cross reactivity). One natural question to ask is how our immune system can 
recognize such a huge amount of different antigens within our living environment. The answer is 
our body maintains a great diversity of T(B)CRs pool, and the generation of their diversity lies at 
the DNA sequence level.  
Lymphocytes can induce irreversible changes to their genomic DNA sequences, which 
results in the great diversity of T(B)CRs pool. The procedure of these changes differs slightly 
between TCR and BCR, but the overall methods are similar with the key part being a step called 
‘V(D)J recombination’
3
 (Figure 1.1). Take the BCR molecule as an example, which is composed 
of two separate chains: light chain and heavy chain. For the heavy chain, the precursor cells of B 
cells have 38-46 Variable (V) genes, 23 Diversity (D) genes and 6 Joining (J) genes in their 
genomic DNA. For each B cell to mature from stem cells into naive B cells, one V gene, one D 
gene and one J gene will be randomly picked out and joined together to become a new DNA 
sequence for translating into BCR amino acid sequence. During the recombination process, 
random insertion or deletion of nucleotides can be added into the junction region between V-D 
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and D-J. This process can induce a great amount of changes on its protein product, including 
BCR heavy chain length, reading frame or even stop codon which results into an ‘unproductive’ 
VDJ recombination. This VDJ recombination step is shared between TCR and BCR, except TCR 
alpha chain and BCR light chain only have V genes and J genes, without D genes. For BCR 
specifically, after the recombination step, random mutations can be introduced into its DNA 
sequence. Termed ‘somatic hyper mutation’ (SHM), this induces another level of diversity for 
BCRs. The junction region between V gene and J gene (including D gene in TCR-beta/BCR-
heavy chain) is called Complementary Determining Region 3 (CDR3), which (as its names 
implies) plays an important role in determining T/BCR’s antigen specificity, because it contains 















To sum up, there are in total four sources of T(B)CR repertoire diversity:  
1). V(D)J combination diversity, which is all the possible combinations between V genes, 
D genes, J genes;  
2). Junction region diversity, which can induce DNA reading frame changes due to 
insertion/deletion of nucleotides;  
3). Alpha-beta chain (TCR) or heavy-light chain (BCR) combinatorial diversity, which is 
due to the random combination between two chains of the duplex;  
4). Somatic hyper mutation diversity, which is introduced by random point mutations 
within BCR sequences.  






 different TCRs 
in theory
19
, although the repertoire of one individual is much less diversified and the diversity 
partially depends on the previous antigen experience history of the immune repertoire. 
1.4 MID BASED IMMUNE REPERTOIRE SEQUENCING 
T/B cells recognize antigens and the recognition will induce changes in the immune repertoire 
(e.g., T cell clonal expansion will change the composition of TCRs). In other words, immune 
cells recognize antigens and clear pathogens while pathogens in return shape repertoire, resulting 
in the change of repertoire composition. Thus, the repertoire becomes a hallmark of an 
individual’s disease states and antigen experience. Traditionally it’s difficult to quantify immune 
repertoire given its huge diversity; however, due to technological advances, researchers 
nowadays can measure immune repertoire by high-throughput sequencing the T/B receptor 





 With the development of high-throughput sequencing, genomic sequencing is becoming 
widely available and the price has dropped significantly since 2001: human whole genome 
sequencing has been dropped from $10 million to $1,000 during the past decades
21
 and the price 
will continue to drop, which allows the wide application of IR-Seq in both research and clinical 
area. However, all current sequencing platforms are suffering from sequencing error, e.g., 
Illumina MiSeq’s reporting error rate is 0.5% errors per bp 
22
.  This error rate may not be a big 
problem in some research areas, for example, whole transcriptome sequencing to analyze gene 
expression value where the sequencing errors can easily corrected by a reference template
23
. 
However in IR-Seq, due to the random insertion/deletion/mutation, genome template reference 
cannot be used to distinguish between real mutations and sequencing error. This is extremely 
important in immune research, because in some cases one single amino acid change can result in 
totally different antigen specificity
24
. An additional source of error, PCR error, will also happen 
during the PCR process
25
. 
In order to perform an accurate measurement of immune repertoire, techniques which can 
eliminate sequencing/PCR errors are essential. Researchers have developed Molecular identifiers 
(MID) to reduce the sequencing error rate within IR-Seq 
26,27
. MIDs are short, randomly 
synthesized DNA sequences which can be tagged to cDNAs during reverse transcription. The 
tagged MIDs go through PCR amplification and high-throughput sequencing in conjunction with 
their labeled cDNAs. Because MID labelling happens before PCR amplification, all the 
sequencing reads originating from the same cDNA will be tagged with the same MID. Thus, 
sequencing reads can be grouped based on their associated MIDs and nucleotides at each 
position within the original cDNA can be determined by finding a consensus. This process is 
essentially involves sequencing the same position multiple times, and because the chance of the 
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same error to happen at the same position is low, the consensus will average out the sequencing 
errors and improve the sequencing accuracy. MIDs are important to achieve a high sequence 

















Chapter 2: MIDCIRS-Molecular IDentifier Clustering-based Immune 
Repertoire Sequencing* 
2.1 INTRODUCTION 
V(D)J recombination can create hundreds of billions of antibodies and T cell receptors that 
collectively serve as the immune repertoire to protect the host from pathogens. Somatic 
hypermutation (SHM) further diversifies the antibody repertoire, which makes it impossible to 
quantify this diversity with nucleotide resolution until the development of high-throughput 
sequencing-based immune repertoire sequencing (IR-seq)
20,28–30
. Although we and others have 
developed methods to control for artifacts from high amplification bias and sequencing error 
rates through data analysis
29,31–35
, obtaining accurate sequencing information has now been made 
possible by the use of molecular identifiers (MID)
26,27,36,37
. MIDs serve as barcodes to track 
genes of interest through amplification and sequencing. They are short stretches of nucleotide 
sequence tags composed of randomized nucleotides that are usually tagged to cDNA during 
reverse transcription to identify sequencing reads that originated from the same mRNA transcript. 
After PCR amplification, sequencing reads labelled with the same MID are amplified from the 







*Ma KY†, He C.†, et al. Immune Repertoire Sequencing Using Molecular Identifiers Enables Accurate Clonality Discovery and 
Clone Size Quantification. Front. Immunol. (2018). doi:10.3389/fimmu.2018.00033.  K-YM performed all library preparation, 
data analysis, and wrote the manuscript; CH developed MIDCIRS-TCR analysis pipeline and RNA copy number simulation 
model; BW helped with naive T cell sorting and manuscript editing; CW helped with CMV-specific T cell sorting and CMV-
specific T cell line culture; JX helped to optimize MIDCIRS pipeline. HY helped with sequencing. NJ conceived the idea, 
designed the study, directed data analysis, and revised the manuscript with contributions from all coauthors.  
†: These authors contributed equally. 
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Despite these advancements, there are still several challenges for correctly applying MID 
technique in IR-seq: 1). The large amount of input RNA required and low diversity coverage 
make it challenging to analyze small numbers of cells, such as memory B cells from dissected 
tissues or blood draws from young children, using IR-seq because these samples require many 
PCR cycles to generate enough material to make sequencing libraries, thus exacerbating PCR 
bias and errors; 2). Same MID may label more than one RNA molecules, which result in chimera 
sequences (Figure 2.1); 3). Erroneous MIDs resulting from PCR or sequencing errors make 
accurate MID counting difficult.  
Here we report the development of MID clustering-based IR-seq (MIDCIRS) that further 
separates different RNA molecules tagged with the same MID. Using naive B cells, we 
demonstrate that MIDCIRS has a high coverage of the diversity estimate, or different types of 
antibody sequences, that is consistent with the input cell number and a large dynamic range of 
three orders of magnitude compared to other MID-based immune repertoire-sequencing 
methods
26,27
. We applied MIDCIRS on CD8+ TCR repertoire with various RNA input amount, 
based on which we demonstrate the necessity of performing MID sub-clustering to eliminate 
erroneous sequences, the method for eliminating erroneous MIDs and how to estimate T cell 
clone size from RNA molecule counting. Given the wide use of IR-seq in basic research
32
 as 
well as clinical settings
38
, we believe the method outlined here will serve as an important 




2Figure 2.1: Representative demonstration of chimera consensus sequences generated 
without sub-clustering. (A). Two different TCR RNAs (RNA2-TCR1 and RNA2-TCR2) were 
tagged with the same MID (RNA2), while one of the TCRs (TCR1) has a sister RNA tagged by 
another MID (RNA1). After building consensus sequence weighted by quality score and number 
of reads at each nucleotide position, a chimera consensus sequence was generated from RNA2-
tagged TCR sequences (Top box, TCR1 tagged with RNA1; bottom box, two TCR sequences 
tagged with same MID; *, sequencing or PCR errors that are removed in the consensus building; 
sequence outside the top box, true TCR1 consensus sequence; sequence outside the bottom box, 
chimera consensus sequence; arrow, chimera nucleotide base that differs from the rest of 
consensus sequence was generated by weighing read number and quality score at each 
nucleotide). (B) Multiple singleton TCR RNAs were tagged with the same MID (RNA1) that 
were generated by either sequencing or PCR errors. without sub-clustering, these singletons 





2.2.1 MIDCIRS Sub-Clustering Improves Repertoire Diversity Estimation Accuracy 
Molecular identifiers have been adopted in IR-seq and DNA/RNA sequencing to reduce error 
rate. However, during reverse transcription, multiple transcripts could stochastically be tagged 
with same MID. Previous strategies relied on increasing the length of MID to reduce the 
probability of non-unique MID tagging when the total RNA molecule copy number was either 
unknown or very large
39
. However, longer MID length could reduce the efficiency of reverse 
transcription
40,41
. Thus, we developed a more generalized approach (MIDCIRS) with reduced 
MID length.  
Figure 2.2 shows the overview of MIDCIRS method. Briefly, we fixed the MID length at 
12 random nucleotides and developed a generalized approach to identify each individual 
transcript using a sequence similarity-based clustering method to separate a group of sequencing 
reads with the same MID into sub-groups. Consensus sequences are then built by taking the 




3Figure 2.2: Overview of MIDCIRS method. Illustration of consensus TCR sequence building 
without (top) and with (bottom) sub-clustering. Top: without sub-clustering, chimera sequences 
are generated when different TCR RNA molecules are tagged with the same MID; bottom: TCR 
RNA molecules that are tagged with same MID are sub-clustered to reveal truly represented 
TCR sequences. Short vertical black lines indicate nucleotide differences between two TCR 
sequences. 
Sub-clustering threshold determination 
An appropriate clustering threshold must be large enough to cover sequencing reads originated 
from the same RNA, while be stringent enough to distinguish reads from different RNAs. In 
order to determine a suitable clustering threshold, we used two template RNAs with known 
sequences and adopted Levenshtein distance
42
 between sequencing reads with the templates to 
quantify the errors accumulated on reads. As in shown in Figure 2.3, we used 150nt sequencing 
length, >99% of reads from both template sequences can be covered at threshold of 23 
14 
 
Levenshtein distance, so we set 15% of sequencing length as a threshold for sub-cluster sequence 
similarity. 
 
4Figure 2.3: Cumulative distribution of reads as a function of Levenshtein distance between 
RNA control templates and sequencing reads. We performed two replicated experiment to test 
the robustness of our determined threshold. 
Theoretical and experimental verified MIDs need sub-clustering 
We reason that in order to comprehensively quantify the overall diversity, a large portion of its 
RNA must be sampled. However, this will inevitably increase the number of TCR transcripts that 
need to be tagged with MIDs, which increases the portion of MIDs tagging multiple TCR 
transcripts. We sought to closely examine the relationship between RNA input and multiple TCR 
RNAs tagging by the same MID.  
15 
 
 The process of MID labeling can be modeled as a Poisson distribution, given the total 
number of MIDs being M and the number of target molecules being N, the probability that a 
unique MID will occur k time(s) is:  









  (1) 
Thus, P0 and P1 are the probability that a MID will be tagged 0 and 1 time respectively and the 
percentage of MIDs that need sub-clustering, F(k>1), is given by: 


















            (2) 
The percentage of MIDs with sub-clusters follows an approximate linear trend when the 
copies of target RNA molecules are less than 5,000,000 (Figure 2.4B). To experimentally 
validate this, we applied MIDCIRS TCR-seq on a range of sorted naive CD8+ T cells (from 
20,000 to 1 million) with three different RNA inputs (10, 30, and 50%). As expected, we found 
that the observed percentage of MIDs that need sub-clustering is approximately linear with 
respect to copies of target RNA molecules used in this study (Figure 2.4A). With the highest 
amount of RNA molecules used in this study, approximately 8.5% of MIDs require further 
clustering, while previous method treated these sequences as ambiguous 
26
. Thus, MIDCIRS sub-




5Figure 2.4: Theoretical and experimental verified MIDs need sub-clustering. (A) The 
percentage of observed molecular identifiers (MIDs) containing sub-clusters is linearly 
dependent on RNA input, which is defined as cell number multiplied by percentage of RNA (e.g., 
20,000 cells with 10%RNA is equivalent to 2,000 RNA input). Line represents linear regression 
fit, F-test on the slope, p < 10
−9
. (B) The theoretical percentage of MIDs with sub-clusters is 
approximately linearly dependent on copies of target molecules when copies of target molecules 
are less than 5,000,000 (bottom right insert). 
To evaluate the accuracy of the sub-clustering step by an alternative means, we examined 
the TCR sequence lengths within MIDs that contain sub-clusters. We reason that if indeed each 
TCR RNA molecule was tagged with a unique MID, then the lengths of CDR3 for all reads 
would be identical under each MID. However, we showed that of the 8.5% of MIDs that contain 
sub-clusters, about 87% of MIDs contain TCR sequencing reads of different CDR3 lengths while 
only 13% have the same length for one million naive CD8+ T cells (50% RNA input). After 
performing sub-clustering, over 97% of sub-clusters have a uniform length (Figure 2.5), 




6Figure 2.5: CDR3 length differences within multi-RNA containing MIDs before and after 
sub-clustering. The number of different CDR3 lengths within multi-RNA containing MIDs from 
one million naive CD8+ T cells (50% RNA input) was plotted before sub-clustering (orange) and 
within the sub-clusters (green). 
Sub-clustering corrects chimera sequences 
More importantly, to our surprise, we found that, without performing sub-clustering, the number 
of unique consensus sequences (unique CDR3 sequences) was overestimated, especially in 
samples with one million cells (Figure 2.6). This is because chimera sequences were generated in 
the consensus building step for two scenarios. In one scenario, multiple true TCR sequences 
could be tagged with the same MID and quality score weighted consensus building will generate 
chimera sequences (Figure 2.1). In the second scenario, PCR or sequencing errors on MIDs 
group multiple singletons (MIDs that contain only one read) under the new MID. If sub-
clustering is applied, then these singletons will be separated and discarded under the singleton 
category. However, without sub-clustering, these singletons will be forced to generate a chimera 
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sequence. Taking together, these chimera sequences cause overestimation of the total TCR 
diversity. The percentage of chimera sequences can be as high as 47% (Table S1).  
 
7Figure 2.6: Rarefaction curve of unique complementarity-determining regions 3 (CDR3s) 
with or without sub-clustering. Number of unique CDR3s in three libraries made with three 
different RNA inputs from sorted one million naive CD8+ T cells. 
MIDCIRS significantly reduces error rate 
We examined the error rate with or without using MIDCIRS on antibody reperotire
43
. Because 
the diversity among hundreds of millions of antigen receptors lies in a short stretch of DNA 
about 60 nucleotides, often two distinct sequences are different by only a few nucleotides. In 
addition, somatic hypermuation, a process that further diversifies the antibody gene sequences, 
has a mutation rate that is comparable to the error rate of the next-generation sequencers. This 
makes estimating the total antigen receptor diversity and tracing the mutational evolution of 
antibody gene sequences difficult. Using MIDs can reduce the error rate by several orders 
magnitude and enable an accurate sequencing and diversity comparison. By comparing 
individual reads within a sub-group to the consensus read, we reached the similar error rate as 





To calculate the improved error rate using the MIDCIRS, we split the total reads into two 
groups, performed clustering separately, and compared the consensus of overlapping sub-groups 
from these two sub-samples. The resulted error rate was 130 fold smaller than the current error 
rate, which reached a quality score of Q45. In addition, while the raw error rate fluctuated 
between runs as demonstrated by the error rate from three runs (Figure 2.7, top panel), the 
improved error rate after using MIDs for these three runs almost did not change (Figure 2.6, 
bottom panel). This comparison can also be used to guide the cluster generation on the sequencer 
to maximize the sequence yield without comprising the sequence quality. Without MIDs, the 
diversity estimate is massively inflated with errors due to PCR and sequencing as demonstrated 
in one experiment where we obtained 1.3 million of reads for one library made from 10,000 cells. 
It generated 258,320 unique raw reads and, even after we took out unique sequences represented 
by only one read, there are still 148,680 unique sequences, which is impossible for a total of 
10,000 cells. This also demonstrates the necessity of using MIDCIRS in immune repertoire 
sequencing.  
 




2.2.2 MID Read-Distribution-Based Barcode Correction Improves Accuracy and 
Sensitivity of Counting TCR Transcripts 
Besides correcting PCR and sequencing errors, MIDs have also been used for absolute 
quantification of RNA molecule copy number in single-cell studies to improve precision
44–47
. 
Here, we demonstrated how to use MIDCIRS TCR-seq to digitally count TCR transcripts. The 
absolute quantification of TCR transcripts is fundamental for accurate clonal size estimation. We 
noticed that PCR and sequencing errors also affected MIDs, as seen in single-cell RNA 
sequencing studies
41,48
, leading to an inflated number of RNA molecules when libraries were 
sequenced exhaustively with respective to the total TCR transcripts in the sample (Figure 2.8). 
To correct MID errors, we first removed singleton reads, which cannot be confidently used in 
generating MID groups due to sequencing errors. Then, we adopted a similar approach applied in 
single-cell RNA-seq by fitting the distribution of reads under each MID subgroup into two 
negative binomial distributions (Figure 2.9)
48
. Erroneous MIDs generated due to PCR errors 
generally have distinctively lower read counts compared with true MIDs. These two negative 
binomial distributions distinctly separated true MIDs from erroneous MIDs. MIDs with low read 
counts were removed accordingly (see Materials and Methods). After MID correction, number of 




9Figure 2.8: Rarefaction curve of detected TCR RNA molecules before and after error 




10Figure 2.9: Distribution of reads under each MID sub-group within example TCR clones. 
The distribution of reads is modeled with a mixed negative binomial distribution with two 
components, reads from the 2
nd
 distribution need to be removed in order to correct MID errors. 
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2.2.3 MIDCIRS yields high accuracy and coverage down to 1000 cells 




) to test the dynamic range of 
MIDCIRS. The resulting diversity estimates, or different types of antibody sequences, display a 
strong correlation with cell numbers at 83% coverage (Fig. 2.10, slope). Previous studies have 
shown that about 80% of naive B cells express distinct heavy chain genes
49,50
, thus our method 
achieves a comprehensive diversity coverage that is much higher than other MID-based antibody 
repertoire-sequencing techniques
26,27,36,37
. Thus, compared with previous IR-seq with MID 
method
26
, MIDCIRS not only can improve the accuracy of diversity estimation but also can 
increase diversity coverage of CDR3. 
 
11Figure 2.10: Correlation between number of cells and number of unique RNA molecules 
after using MIDCIRS. RNA from as few as 1000 to as many as 1,000,000 naive B cells was 




2.2.4 Theoretically and experimentally measured TCR RNA molecule copy number per cell  
After MID sub-clustering and MID correction, theoretically MIDCIRS can capture all the RNA 
molecules within a sample. However, due to the experiment efficiency and removing erroneous 
MIDs, we are never going to cover all the RNA molecules in a bio-sample. One question is 
researchers may be interested is: what’s the efficiency of MIDCIRS, i.e. the percentage of TCR 
RNAs covered within the total TCR RNA molecules. In order to estimate the efficiency, we 
adopted two ways to calculate the average TCR RNA copy number per CD8+ naive T cell (m), 
which is an unknown parameter yet: one is to directly fit the number of RNA molecules we 
observed versus the RNA we inputted and the slope will be ‘m’; the other way is to develop a 
statistical model which predict ‘m’ based on the number of unique TCR molecules we observed. 
 Figure 2.11 shows the result of the first way of modeling number of observed RNA 
versus number of inputted RNA (‘number of cells’ times ‘percentage of RNA input’), we fitted a 
line across all the data points we measured. The slope shows the average RNA copy number per 






12Figure 2.11: Observed RNA versus inputted RNA. X axis shows the experimental cell 
numbers and RNA input percentage, Y-axis shows the number of MIDCIRS’ observed RNA 
molecules. The slope shows the estimated RNA copy number per cell. 
 The second way is to develop a statistical model based on number of unique RNA 
observed versus the inputted RNA while treat the number of observed RNA molecues as an 
unknown parameter. For N observed RNA molecules, there are K different RNA clones. The 
RNA molecule copy number of each clone is mi (i ∈ (1, K)), whose sum equals N. After fitting 
the data, mi follows a power law distribution
29,51
 (Figure 2.12): 
 𝑚𝑖 = 𝑚 × 𝑥𝑖 (3) 
 𝑓(𝑥𝑖) = (𝛼 − 1)𝑥𝑖
−𝛼 , (𝛼 > 1)   (4) 
(m is the RNA molecule copy number per cell, which is a constant across all T cells. xi 
represents the cell numbers of each clone, which follows a power law distribution, and the 
parameter α was fitted with an algorithm combining maximum-likelihood fitting and goodness-
of-fit test based on Kolmogorov-Smirnov statistic
52




y = 3.2283x - 14267 




































Number of cells multiplied by Percentage of RNA input 
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, (𝛼 > 1) (5) 
Since ‘m’ is a constant, the alpha in equation (4) and (5) should be equal. We fitted across all 
libraries on log-log scale, and the average slope was taken as α in the above model. 
When we sample n RNA molecules from this population, the expected detected diversity, 
E(D), can be calculated as the following:  
 
𝐸(𝐷|𝑚, 𝑥𝑖) =  𝐾 −






, 𝑥𝑖 = (𝑥1, 𝑥2, … , 𝑥𝐾) (6) 
And xi can be sampled from the fitted power law distribution. 
Then, the percentage of the RNA diversity coverage, P(D), can be estimated as:  
 




We then used equation (8) to get estimated m: 
 min
𝑚
∑(𝑃(𝐷𝑖|𝑚, 𝑥𝑖) − 𝐷𝑜𝑏𝑠)






13Figure 2.12: TCR clone size distribution of naive CD8+ T cells. Red dashed line is the fitted 
power law distribution. 
Using the model above, we predict ‘m’, which is the average TCR RNA per cell, to be 
equal to 3, and the results are shown in Figure 2.13A. The RNA copy numbers estimated by both 
ways agree with each other, which demonstrate the accuracy of digit counting RNAs with 
MIDCIRS. The 2
nd
 way of modelling treated MID numbers as an unknown parameter and we 
used the 1
st
 way to validated out prediction after sequencing much more reads from the library. 
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This result shows MIDCIRS is able to capture almost all the MID labeled RNA molecules. We 
experimentally measured the average RNA copy per cell digital PCR, digital PCR measured 
TCR RNA copy per cell is 8~12(Figure 2.13B), this differ is mainly during the Reverse 
Transcription step (RT) and PCR steps. In summary, the results all together represent MIDCIRS 
efficiency is ~30%.  
 
14Figure 2.13: Modelling and digital measuring TCR RNA copy per cell. A). Curve fitting of 
diversity coverage as a function of different RNA input with 3 as predicted TCR RNA molecule 









2.2.5 Naive TCRs serve as guideline for sequencing depth  
While designing a sequencing experiment, it’s hard to determine a suitable sequencing depth that 
is able to cover all the diversity (unique RNA) or RNA molecules. One way researchers normally 
performing is to sequence multiple times, with each time adding more sequencing reads to check 
whether all the unique RNAs have been covered and pool all the reads together as the final 
sequencing pool, which is very inefficient. Our experiment on naive TCRs provides a good 
bottom line for researchers, because naive cells are generally more diverse than other cell 
populations since naive T cells have little clonal expansion. Certain sequencing depth can cover 
all the diversity within naive TCR repertoire will definitely be able to cover diversity in other 
cell population.  We found that a shallower sequencing depth is required to saturate unique 
CDR3s than RNA molecules. In addition, the amount of diversity covered increased with 
increasing RNA input. Thus, to exhaustively measure the TCR repertoire diversity, with 30–50% 
of RNA input, a sequencing depth equivalent to 10 times the cell number covers most of the 
CDR3 diversity, while a sequencing depth equivalent to about 100 times the relative RNA input 
(defined as cell number multiplied by percentage of RNA input) is required to saturate the RNA 
molecules. For example, 30% RNA of 20,000 cells is equivalent to 6,000 RNA input. Then, it 








2.3 MATERIALS AND METHODS 
Naive CD8+ T Cell Sorting 
Human leukocyte reduction system chambers were obtained from de-identified donors at We Are 
Blood (Austin, TX, USA) with strict adherence to guidelines from the Institutional Review 
Board of the University of Texas at Austin. CD8+ T cell enrichment was done following the 
protocol described previously
54
 using RosetteSep CD8+ T Cell Enrichment Cocktail 
(STEMCELL) together with Ficoll-Paque (GE Healthcare). Then, RBCs were lysed using ACK 
Lysing Buffer (Lonza). After washing in phosphate-buffered saline with fetal bovine serum, the 
cell mixture was passed through a cell strainer (Corning) and ready for use. Naive CD8+ T cells 
were FACS-sorted into RLT Plus buffer (Qiagen) supplemented with 1% β-mercaptoethanol 
(Sigma) based on the phenotype of CD8+CD4-CCR7+CD45RA+ using BD FACSAria II cell 
sorter. 
Bulk TCR Library Generation and Sequencing 
Total RNA was purified using All Prep DNA/RNA kit (Qiagen) following the manufacturer’s 





. Reads of the same library from all runs were combined and analyzed. 
dPCR of TCR 
Total RNA purified from sorted CD8+ T cells and cultured CMV-specific CD8+ T cell lines 
were reverse transcribed with polyT primers
55
 using Superscript III in 20 μl reaction following 
the manufacturer’s protocol. 2 μl of cDNA was subsequently used on QuantStudio 3D dPCR 
system following manufacturer’s protocol. 
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Preliminary Read Processing 
First, only reads that have exact TCR constant sequences were kept for further analysis. These 
reads were then cut to 150 nt starting from constant region to eliminate high error-prone region at 
the end of reads. These preprocessed reads were split into MID groups according to 12-nt 
barcodes. 
MID Sub-Cluster Generating and Filtering 
For each MID group, a quality threshold clustering was used to group reads derived from a 
common ancestor RNA molecule and separate reads derived from distinct RNAs. Briefly, a 
Levenshtein distance of 15% of the read length was used as the threshold. For each subgroup, a 
consensus sequence was built based on the average nucleotide at each position, weighted by the 
quality score. In the case that there were only two reads in an MID subgroup, we only considered 
them useful reads if both were identical. Each MID subgroup is equivalent to an RNA molecule. 
Next, we merged all of the identical consensus to form unique consensus sequences. Further, we 
applied filtering of unique consensus sequences after sub-cluster generation by (a) removing 
non-functional TCR sequences and (b) removing sequences with lower MID counts that are one 
Levenshtein distance away from the other. Then, for each unique consensus sequence, we 
removed MID sub-clusters if their reads are less than 20% of maximum read count based on the 
fitting of two negative binomial distribution (Figure 2.8). Scripts for this section can be 






Mann–Whitney U test was used to calculate the significance of copy number difference between 
pairs in naive, effector, effector memory, and central memory CD8+ T cells and p values was 



















We applied the MIDCIRS in T cells to demonstrate: 1) the necessity of MID sub-clustering to 
improve accuracy of repertoire diversity estimation; 2) erroneous MID correction eliminates 
overestimate of TCR RNAs; 3) the accuracy of counting TCR RNA molecules via MID read-
distribution based barcode correction and 4) wide dynamic range of MIDCIRS. 
Previous MID-based IR-seq methods, such as MIGEC, build TCR consensus sequences 
by grouping MIDs
26,56
. However, the number of target molecules could vary significantly with 
different sample inputs, which could be challenging for choosing the appropriate MID length to 
ensure that each target RNA molecule is uniquely tagged by MID. Longer MIDs are likely to 
decrease the reverse transcription efficiency
40,41
. Thus, the MIDCIRS method offers a flexible 
strategy for MID-barcoded IR-seq. In addition, MIGEC triages MIDs with high diversity as 
ambiguous. We compared TCR diversity discovered using MIDCIRS with that of MIGEC, using 
MID with at least two reads as the threshold for both approaches and found that MIGEC led to 
an underestimated TCR diversity (Figure S1, p < 0.001, effect size r = 0.62). We demonstrated 
that using MID-based sub-clustering approach, MIDCIRS could identify new diversities, prevent 
chimera sequences from being built, and digitally count RNA molecules. This corrected diversity 
is highly consistent with cell input numbers. 
While MIDs are useful to correct for sequencing errors and PCR errors that occur on 
TCR sequences, such errors are also likely to show up on MID sequences. Although these errors 
do not affect TCR diversity estimation, they lead to an overestimation of transcript copies, thus 
misestimating TCR clone size. We corrected MID errors based on the distribution of MID read 
counts under MID subgroups. With MID correction, we were able to accurately count TCR RNA 
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molecule copy number, estimate MIDCIRS detection limit as well as detect T cell clonal 
expansion. 
Based on the TCR diversity estimation and its dependency on RNA input, we built a 
probability model to estimate TCR RNA molecule copies, which resulted in three copies per cell. 
We would like to point out that this does not mean that on average there are three copies of TCR 
RNA in a T cell. Because of the efficiency of RNA purification and reverse transcription, we 
expect our observed RNA molecule per cell to be lower than the true value. In Fact, dPCR 
results showed an average of 10 copies of TCR RNA molecule per cell, suggesting the efficiency 
of MIDCIRS in TCR RNA molecule digital counting is about 30%, which is consistent with 
previous finding that nanoliter reaction volume significantly improved PCR efficiency. Thus, 
quantifying TCR RNA molecule per cell enables us to estimate the extent of T cell clonal 









Chapter 3: MIDCIRS application in biomedical study helps understanding 
antigen driven immune response 
Having demonstrated the high coverage, accuracy and dynamic range of MIDCIRS in immune 
repertoire sequencing in Chapter 2, we applied MIDCIRS on real patient samples to study 
antigen driven immune responses of immune repertoire.  
Chapter 3 contains two separated studies focusing on MIDCIRS applications in TCR 
repertoire and antibody repertoire:  
We applied MIDCIRS on HIV patients, analyzed their TCR repertoire and found 
evidence for 1) intact antigen-driven clonal expansion of Tfh cells and 2) selective utilization of 
specific complementarity-determining region 3 (CDR3) motifs during chronic HIV infection
57
.  
We used MIDCIRS to study malaria infected children samples, analyzed their antibody 
repertoire and found unexpected mutation capability of immune system in infants
43
.  










3.1 APPLICATION OF MIDCIRS ON TCR REPERTOIRE: THE RECEPTOR REPERTOIRE AND 
FUNCTIONAL PROFILE OF FOLLICULAR T CELLS IN HIV-INFECTED LYMPH NODES* 
3.1.1 Introduction 
Follicular helper T cells (Tfh) provide key signals necessary for B cell recruitment and selection 
to generate protective antibody responses
15,58
. During untreated chronic HIV infection, Tfh cells 
become highly expanded in the lymph nodes (LNs)
59,60
. Despite this, HIV+ patients generate 
diminished protective antibody responses against immune challenges. For example, HIV-
infected individuals produce lower titers of antibodies and less durable responses to seasonal 
influenza vaccines
61
. The prevailing model suggests that Tfh cells from HIV patients are 
ineffective at providing B cell help based on in vitro assays that showed less robust antibody 
production by B cells co-cultured with Tfh cells from HIV+ patients
62–64
. A proposed mechanism 
for this involves up-regulation of programmed cell death–ligand 1 (PD-L1) by B cells, which 
interacts with programmed cell death–1 (PD-1) on Tfh cells to inhibit T cell receptor (TCR)–
dependent activation of Tfh cells
62
. However, the extent to which Tfh cells express impaired 
antigen responsiveness in vivo remains unclear. Because Tfh cells need to appropriately sense 
antigen signals to discriminate between B cells, defective response to antigen not only impairs 






* Wendel, B. S.†, Del Alcazar D†., He C†. et al. The receptor repertoire and functional profile of follicular T cells in HIV-infected lymph 
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Here, we analyzed the TCR repertoire composition of primary Tfh cells isolated directly 
from LNs from untreated HIV+ individuals. We used the presence or absence of antigen-
dependent TCR signatures to address the responsiveness of Tfh cells to antigen engagement. Our 
TCR repertoire data revealed clonal expansion and convergent selection for Gag-reactive TCRs 
in Tfh cells in the germinal centers (GCs) of HIV-infected LNs, indicating that Tfh cells remain 















HIV-infected LNs contain clonally expanded GC Tfh cells 
LNs from untreated HIV+ patients contain a high frequency of Tfh cells, but the mechanism that 
drives expansion of Tfh cells remains unclear. The enrichment of HIV antigens
65,66
 and the 
highly pro-inflammatory milieu
67,68
 in the LNs could lead to antigen-driven and/or bystander T 
cell expansion. To address whether proliferation of Tfh cells is antigen-dependent, we tested 
whether HIV induces selective proliferation of certain T cell clones. We focused on GC Tfh cells 
because the frequency of these cells becomes greatly increased during chronic HIV infection
59,60
. 
To identify GC Tfh cells, we selected memory CD4+ T cells that express Tfh cell markers 
CXCR5 and PD-1. CD57 is a glycan carbohydrate epitope expressed by Tfh cells in the GC, and 
we used this marker to further demarcate the GC subset 
69–72
. Naive CD4+ T cells were identified 
by CD45RO−CXCR5−CD57−CCR7+ expression, and memory CD4+ T cells were identified by 
CD45RO+CXCR5− staining and excluded for PD-1 and inducible T cell co-stimulator (ICOS)–
positive cells (Figure 3.1A). We sorted 1464 to 15,000 naive, memory, and GC Tfh cells from 
freshly thawed LN samples and analyzed the TCR sequences of these subsets using MIDCIRS to 
increase the accuracy of repertoire sequencing 
43,55
. Because the variability of TCR sequences is 
encoded in the complementarity-determining region 3 (CDR3) region, we used the number of 
transcripts detected for a particular CDR3 sequence to define TCR clone size. On average, 
11,839 TCR transcripts were detected for each sample (table 3.1). Unique TCR frequencies 
range from 1 in 37,129 (0.003%) for the rarest clones to 250 in 2498 (~10%) for the most 
expanded clone. To compare the degree of relative clonal expansion, we categorized TCR 
frequency into six groups, ranging from rare (<0.1%) to >2%, according to the clone size relative 
to the total TCR transcripts detected in that sample. As expected, the TCR repertoire of naive 
CD4+ T cells was composed mostly of rare clones. In contrast, the TCR repertoire of GC Tfh 
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cells had a much higher fraction of TCRs occupied by abundant clones (>0.1%) compared with 
naive and memory CD4+ T cells (Figure 3.1B and figure 3.2). The degree of TCR clonal 
expansion was quantified by normalized Shannon entropy (NSE)
73,74
. Consistent with the 
hypothesis that the increase in GC Tfh cell frequency is due to selective proliferation of certain T 
cell clones, GC Tfh cells had a lower NSE score compared with naive and memory cells (Figure 






15Figure 3.1: GC Tfh cells become clonally expanded. (A) Representative plots showing sorting 
strategy to identify naive, memory, and GC Tfh cells. (B) Breakdown of the proportion of the 
TCR repertoire represented by clones of different sizes for sorted naive, memory, and GC Tfh 
cells from HIV+ LNs. TCR clone size was normalized by the total number of TCR transcripts on 
nucleotide sequences. (C) NSE of the TCR repertoire of sorted naive, memory, and GC Tfh cells. 
Gray lines link the same patient. Bars indicate means. *P < 0.05 by two-tailed Wilcoxon signed-




16Figure 3.2: GC Tfh cells are clonally expanded. Breakdown of the proportion of the TCR 
repertoire represented by clones of different sizes for sorted naive, memory, and GC Tfh cells 
from HIV+ LNs for each individual.  TCR clone size was normalized by the total number of 




TCRs from GC Tfh cells exhibit signatures of antigen-driven clonal convergence 
Next, to test whether clonal expansion in GC Tfh cells from HIV-infected LNs was antigen-
driven, we analyzed the TCR sequences for evidence of convergence to the same amino acid 
sequence from distinct nucleotide sequences. Unlike B cells, which can undergo somatic 
hypermutation, the TCR sequence of a naive T cell is determined during maturation in the 
thymus and remains fixed throughout the life spans of the T cell and its progeny. Thus, with the 
exception of clones that express two TCRa or TCRb sequences, distinct TCR nucleotide 
sequences necessarily arise from distinct naive T cells. However, multiple nucleotide sequences 
of different TCRs may encode the same amino acid sequence. These degenerate TCR sequences 
are typically rare, and the presence of these sequences suggests antigen selection pressure that 
favors certain TCR motifs that recognize particular antigen(s). Thus, having highly abundant 
CDR3 amino acid sequences that are encoded by multiple distinct nucleotide sequences indicates 
preferential expansion of T cells with that specificity
73
. On the other hand, we would not expect 
multiple nucleotide sequences to converge on the amino acid level in the absence of strong 
antigen-driven selection. Following this logic, we translated the TCR nucleotide sequences into 
amino acid sequences and tallied the number of different nucleotide sequences that encode each 
CDR3 amino acid sequence. These CDR3 amino acid sequences can be broken into four 
quadrants—Q1, Q2, Q3, and Q4—based on the level of degeneracy and frequency in the 
repertoire (Figure 3.3A and Figure 3.4). Q1 contains highly expanded amino acid CDR3 
sequences that are encoded by two or more nucleotide sequences (Figure 3.3B). These 
degenerate, abundant clones likely arose from strong antigen-driven selection and proliferation. 
Q2 contains low-frequency amino acid CDR3 sequences that are also encoded by two or more 
nucleotide sequences. Degenerate clones can stochastically arise in the repertoire, but these are 
typically rare as reflected by the low frequency of non-clonally expanded sequences in Q2. Q3 
42 
 
contains amino acid CDR3 sequences that show neither clonal expansion nor amino acid 
convergence and make up most of the repertoire. Q4 contains expanded amino acid CDR3 
sequences derived from a single nucleotide sequence and are therefore nondegenerate. This TCR 
degeneracy analysis revealed a significantly higher degree of antigen-driven clonal convergence 
in GC Tfh cells compared with naive and memory T cells (Figure 3.3C). Together with the NSE 
decrease in GC Tfh cells, these data provide further evidence that antigen-driven clonal 











17Figure 3.3: Antigen-driven clonal selection signature in GC Tfh cells of HIV-infected LNs. 
(A) Representative degeneracy plot from sample H2. Coding degeneracy level [number of 
unique TCR nucleotide (nt) sequences encoding a common CDR3 amino acid sequence] of each 
CDR3 amino acid sequence is plotted against their frequency (measured as percentage of total 
TCR transcripts) in naive, memory, and GC Tfh cells. Each dot is a unique CDR3 amino acid 
sequence. Red dashed lines indicate cutoffs for degenerate (two or more nucleotide sequences 
coding for the same amino acid sequence; horizontal) and expanded (0.1% or more of TCR 
transcripts; vertical) clones. Red arrow points to example degenerate clone in (B). (B) Example 
of CDR3 amino acid degeneracy. Amino acid (top row) and nucleotide (bottom row) sequences 
for three distinct nucleotide sequences (0.41% of total TCR transcripts) that code for the same 
amino acid sequence as indicated by arrow in (A): Y = 3 and X = 0.41%. Red boxes and 
highlights indicate redundant codons. (C) Comparison of Q1 degenerate-abundant clone 
percentage in naive, memory, and GC Tfh cells. Gray lines link the same patient. Bars indicate 




18Figure 3.4: Antigen-driven clonal selection signature in GC Tfh cells of HIV-infected LNs. 
Coding degeneracy level (number of unique TCR nucleotide (nt) sequences encoding a common  
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Figure 3.4 cont. 
CDR3 amino acid (aa) sequence) of each CDR3 aa sequence is plotted against their frequency 
(measured as % of total TCR transcript) in naive, memory, and GC Tfh cells. Each dot is a 
unique CDR3 aa sequence. Red dashed lines indicate cutoffs for degenerate (2 or more nt 
sequences coding for the same aa sequence, horizontal) and expanded (0.1% or more of TCR 
transcripts, vertical) clones. Each panel is broken into 4 quadrants: Q1: degenerate-abundant 
clones; Q2: degenerate-rare clones; Q3: nondegenerate-rare clones; Q4: nondegenerate-abundant 
clones.  
HIV promotes selective expansion of HIV-reactive Tfh cells 
To determine whether clonally expanded and/or convergently selected TCRs include HIV-
specific sequences, about 2 to 3 million thawed LN cells were cultured with an HIV-1 consensus 
B Gag peptide pool for 3 to 4 weeks and then re-stimulated with the same peptide pool for 4 
hours to identify antigen-specific T cells by CD40L and CD69 up-regulation (Figure 3.5). LN 
cells were also stimulated with an overlapping set of hemagglutinin (HA) peptides from 
influenza virus (A/California/7/2009) as a non-HIV control. TCRs from CD40L+CD69+ Gag- or 
HA-reactive T cells were used to generate a reference TCR panel (Table S2). These antigen-
specific TCR sequences (Table S4) were mapped onto our bulk T cell sequencing data from 
freshly thawed LN cells to determine which sequences were Gag- or HA-specific. Common 
sequences shared between naive, memory, or GC Tfh cells were shown as connecting lines on 
circos plots (Figure 3.6A). 
We found several Gag-specific TCR sequences in the GC Tfh (zero to seven clones) 
population. Although we did not have enough data points to reach significance, the overlap 
between Gag-specific TCR sequences was minimal in memory T cells (zero or one clone), and 
no Gag-specific sequences were found in the naive T cell population (Figure 3.6B). A similar 
trend of enrichment of antigen-specific clones in the GC Tfh cells was also observed for HA-
specific TCR sequences (Figure 3.7). This is unsurprising because these individuals have likely 
been exposed to influenza infection and/or vaccinated against HA in the past. However, analysis 
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of combined TCR sequencing data from all individuals showed that these Gag-specific GC Tfh 
cells, but not the HA-specific clones, were highly expanded compared with the bulk GC Tfh 
cells of unknown specificity (Figure 3.6C). Translating these antigen-specific TCR sequences 
into amino acid sequences showed that the Gag-specific TCR sequences within the GC Tfh 
population, but not the HA-specific sequences, have a significantly higher degree of coding 
degeneracy (Figure 3.6D). Thus, the Gag-specific GC Tfh cells were preferentially expanded and 
degenerate. Collectively, these data indicate that Gag-specific Tfh cells respond to antigen 
stimulation and become selectively expanded in the LNs. 
 
19Figure 3.5: Identification of Gag- or HA-reactive T cells in cultured cells.  LN cells were 
cultured with Gag or HA peptide pools for 3-4 weeks, then re-stimulated with peptides for 4  
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Figure 3.5 cont. 
hours.  (A-B) T cells specific to Gag or HA were identified by positive CD40L and CD69 
staining.  Representative plots showing antigen-specific T cells that responded to Gag peptides 
(A) or HA peptides (B). 
 
20Figure 3.6: GC Tfh cells exhibit HIV antigen–driven clonal expansion and selection. (A) 
Gag-specific TCR clones overlap with HIV+ LN CD4+ T cell populations. Each thin slice of the 
arc represents a unique TCR sequence, ordered by the clone size (darker green for larger clones, 
inner circle). Gray curves indicate Gag-specific TCR nucleotide sequences found in naive (gray, 
outer circle), memory (blue, outer circle), and GC Tfh (orange, outer circle) populations. No Gag 
overlapping clones were detected for one individual, H8 (not shown). (B) Number of Gag-
specific TCR clones observed in naive, memory, and GC Tfh populations. Gray lines link the 
same patient. Bars indicate means (P values by two-tailed paired t test). (C) Mean clone size of 
Gag-specific T cells, HA-specific T cells, and bulk clones of unknown specificity from the GC 
Tfh population. (D) Number of distinct nucleotide (nt) sequences per CDR3 amino acid (aa) 
sequence for Gag-specific T cells, HA-specific T cells, or bulk GC Tfh cells. Data from all four 
individuals were aggregated for (C) and (D). Error bars indicate SEM. N.S., not significant. ***P 




21Figure 3.7: HA-specific CD4 T cell clones detected in HIV-infected LNs. (A) HA-specific 
TCR clones overlap with HIV+ LN CD4+ T cell populations. Each thin slice of the arc 
represents a unique TCR sequence, ordered by the clone size (darker green for larger clones, 
inner circle). Grey curves indicate HA-specific TCR nucleotide sequences found in naive (black, 
outer circle), memory (blue, outer circle), and GC Tfh (orange, outer circle) populations. No HA-
overlapping clones were detected for one subject, H2 (not shown). (B) Number of HA-specific 
TCR clones observed in naive, memory, and GC Tfh populations. Grey lines connect samples 





3.1.3 Materials and Methods 
Study design 
The goal of the study was to define Tfh cell diversity in primary human LNs. All samples were 
de-identified and obtained with Institutional Review Board approval from the University of 
Pennsylvania. 
CyTOF staining 
Metal conjugation of CyTOF antibodies was performed according to the manufacturer protocol 
using the X8 Maxpar kit (Fluidigm). Cells were stained with antibody panel, washed three times, 
then resuspended in 2% paraformaldehyde (Electron Microscopy Sciences) with 125nM iridium 
intercalator (Fluidigm) for an overnight incubation at 4
o
C.  The next day, cells were washed 
three times, including a final wash in distilled water, and resuspended in water containing 
normalization beads before acquisition on CyTOF 2. 
Flow-cytometry based antibody staining 
Identifying bulk T cell subsets for direct sequencing: Cryopreserved were stained with CD4-
AF700 (OKT4, eBioscience), CD11b-PE/cy5 (ICRF44, Biolegend), CD19-PE/cy5 (HIB19, 
Biolegend), and CD8-PE/cy5 (HIT8a, Biolegend) in the dump channel, fixable aqua dye 
(ThermoFisher) for live/dead discrimination, CD57-FITC (HCD57, Biolegend), CD45RO-
BV605 (UCHL1, Biolegend), CXC5-PE/TexasRed (J252D4, Biolegend), ICOS-APC (C398.4, 
Biolegend), PD-1-BV785 (EH12.2H7, Biolegend), CCR7-PE/cy7 (G043H7, Biolegend).  LN 
cells were sorted by naïve (CD45RO-CXCR5-CD57-CCR7+), memory (CD45RO+CXCR5-PD-




Identifying antigen-specific T cells:  Peptide-reactive T cells were identified using the 
following antibodies depending on the experimental condition: CD40L (24-31, Biolegend), 
CD69 (FN50, BD biosciences), anti-IL-21 APC antibody (3A3-N2, Biolegend), Ox40 (Ber-
ACT35, Biolegend), CD25 (BC96, Biolegend). 
TCRb sequencing and analyses 
TCR sequences from single cells were obtained by a series of three nested polymerase chain 
reactions, as previously described 
75,76
. TCR junctional region analysis was performed using 
IMGT/V-Quest. For bulk cell analyses, TCR library generation and raw sequence processing 
were performed using MIDs with primers listed in Table S3
43,55
. 
Clone size distribution and normalized Shannon entropy:  The size of each TCR clone was 
determined by the number of TCR transcripts of that sequence detected. The sizes were then 
normalized by the total number of TCR transcripts detected in that sample to yield the relative 
clone size in percent.  Normalized Shannon entropy was calculated as previously described
73
. 
Amino acid translation and degeneracy:  The CDR3 blast module of MIGEC
26
 was used to 
translate the CDR3 nucleotide sequences into amino acid sequences. For each amino acid CDR3 
sequence, the number of distinct nucleotide sequences (TCR clones) encoding that amino acid 
CDR3 sequence was tallied as the degree of degeneracy
73
. Amino acid CDR3 sequences encoded 
by 2 or more TCR clones were labeled as degenerate, and degeneracy versus relative clone size 
was analyzed to identify expanded, degenerate clones. 
Antigen-specific TCR identification:  TCR clones from the peptide-stimulated cells were used 
to establish donor-specific Gag- and HA-specific TCR sequences. TCR clones found in both the 
Gag- and HA-stimulated cultures were eliminated, as they likely originated from basally 
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activated T cells within the initial LN sample. These antigen-specific sequences were then 
queried in the bulk naïve, memory, and GC TFH cells to identify Gag- and HA-specific clones 
within the respective populations. Circlize R package
77
 was used to visualize circus plots.    
Statistical methods 
Assessment of normality was performed using D’Agostino-Pearson test. Pearson or Spearman’s 
rank correlation was used depending on the normality of the data to measure the degree of 
association. The best-fitting line was calculated using least-squares fit regression. Statistical 
comparisons were performed using two-tailed Student’s t test or Wilcoxon signed-rank test, with 
a P value of <0.05 as a cutoff to determine statistical significance. Multiple comparisons were 













How HIV affects lymphoid Tfh cells has been studied under limited settings. In part, the 
challenge has been the inaccessibility of human lymphoid tissues and the tools available to 
interrogate a small number of cells. Here, we overcame these challenges using LNs obtained for 
clinical diagnostics from a mostly untreated HIV+ cohort. The data described here represent a 
comprehensive phenotype and TCR analysis of Tfh cells in the LNs, including that of HIV-
reactive T cells. We also analyzed LN samples from HIV− HCs, but because of ethical and 
practical limitations, HC-derived LNs were obtained from different body sites and should be 
interpreted with this potential caveat. Our data based on TCR repertoire sequencing analyses 
provided evidence for antigen-driven expansion of Tfh cells and selection for certain preferred 
CDR3 sequences during chronic HIV infection. We further demonstrated that these GC Tfh cells 
acquire a distinct functional phenotype and become dominated by an IL-21+ functional subset. 
We used HIV infection to ask how prolonged antigen stimulation alters the composition 
of Tfh cells in the LN. In vitro studies have suggested that Tfh cells could become inhibited in 
the context of chronic inflammation and fail to activate appropriately to TCR stimulation via 
induction of PD-1–mediated inhibitory signals
62
. The increase in Tfh cells could then be 
explained by an overabundance of cytokine signals in HIV-infected LNs that activated T cells in 
an antigen-independent fashion
67,68
. Although our data do not rule out a contribution from 
bystander T cell expansion, our data are most consistent with the model where Tfh cell pathology, 
manifested as clonal expansion and reduced poly functionality, is primarily an antigen-driven 
process. By TCR repertoire sequencing, we showed that certain TCR clonotypes become 
expanded within GC Tfh cells. A small portion of HIV-specific clones harbor distinct nucleotide 
sequences that converge to the same amino acid sequence—a signature of antigen-driven 
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selection. Convergent selection of TCR sequences is expected only when there is external 
pressure to select for certain CDR3 binding motifs. These data provide strong evidence for an 
antigen-driven process and additionally suggest that B cells, in their capacity as antigen-
presenting cells, also shape the composition of Tfh cells. We measured the extent of clonal 
restriction by single-cell TCR sequencing. We found different clonal frequencies in Gag-reactive 
IL-21+ T cells between different HIV+ patients, with expanded clones occupying a significant 
proportion of Gag-reactive response in some individuals. Although we did not evaluate Env-
reactivity directly, reduced TCR diversity will likely also affect T cells that recognize other HIV 
antigens. How Tfh cell repertoire relates to the selection of protective and/or neutralizing 
antibody responses remains poorly understood. The density of peptide–major histocompatibility 
complex (MHC) presented by competing B cells has been shown to be a major factor that 
determines the magnitude of T cell help 
78–80
, but the diversification of antigenic variants by viral 
mutation provides an additional layer of complexity in the selection of relevant B cells during 
chronic HIV infection
81
. Previous studies have shown that early HIV Env gene diversity predicts 
development of antibody breadth
82
. This raised the possibility that a diverse repertoire of HIV-
specific Tfh cells may be necessary to capture the breadth of viral variants, and an oligoclonal 
Tfh population that focuses T cell reactivity to nonproductive but common antigenic viral 
sequences may neglect rare B cells that have neutralizing potential. Future studies to determine 
whether individuals with more diverse HIV-specific Tfh cell repertoire are more successful at 





3.2 APPLICATION OF MIDCIRS ON ANTIBODY REPERTOIRE: ACCURATE IMMUNE REPERTOIRE 
SEQUENCING REVEALS MALARIA INFECTION DRIVEN ANTIBODY LINEAGE DIVERSIFICATION IN 
YOUNG CHILDREN* 
3.2.1 Introduction 
MIDCIRS' high coverage and dynamic range allow us to sequence samples with very few cells, 
for example, infant blood samples. We use MIDCIRS to examine the antibody repertoire 
diversification in infants (<12 months old) and toddlers (12–47 months old) from a malaria 
endemic region in Mali before and during acute Plasmodium falciparum infection. Although the 






, and the elderly
85,86
 has been studied, 
infants and toddlers are among the most vulnerable age groups to many pathogenic challenges, 
yet their immune repertoires are not well understood. Infants are widely thought to have weaker 
responses than toddlers to vaccines because of their developing immune systems
87
. Thus, 
understanding how the antibody repertoire develops and diversifies during a natural infection, 
such as malaria, not only provides valuable insight into B cell ontology in humans, but also 







* Wendel, B.S.†, He C.†, Qu M.† et. al. Accurate immune repertoire sequencing reveals malaria infection driven antibody 
lineage diversification in young children. Nat. Commun. 8, 531 (2017). B.S.W. performed all malaria related experiment and 
part of data analysis; C.H. performed antibody sequencing, mutation and selection pressure analysis; M.Q. developed the 
sequencing protocol using sorted naive B cells; D.W. helped with sequence analysis; S.M.H. helped with library 
construction; K.Y.M. helped with sequencing; J.X. helped with lineage visualization, E.W.L, P.D.C., and S.K.P. selected 
malaria patients, provided samples and helped with experimental design; P.R. provided computation resources and helped 
with analysis; K.C. helped with lineage structure algorithm optimization and lineage visualization; N.J. conceived the idea, 
designed the study, and directed data analysis; B.S.W. and N.J. wrote the paper with contributions from all co-authors. 
†: These authors contributed equally. 
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Using peripheral blood mononuclear cells (PBMC) from 13 children aged 3–47 months 
old before and during acute malaria, with two of the children followed for a second year and nine 
additional pre-malaria individuals we show that infants and toddlers use the same V, D, and J 
combination frequencies and have similar complementarity determining region 3 (CDR3) length 
distributions.  
Although infants have a lower level of average SHM than toddlers, the number of SHMs 
in reads that mutated in infants is unexpectedly high. Infants have a similar, if not higher, degree 
of antigen selection strength, assessed by the likelihood of amino acid-changing SHMs, 
compared with toddlers. Remarkably, during acute malaria, antibody lineages expand in both 
infants and toddlers, and this expansion is coupled with extensive diversification to the same 
degree as in young adults in response to acute malaria
88,89
. In summary, using an accurate and 
high-coverage IR-Seq method, we discover features of the antibody repertoire that were 
previously unknown in infants and toddlers, shedding light on the development of the immune 









Infants and toddlers have similar VDJ usage and CDR3 lengths. 
Equipped with this ultra-accurate and high-coverage antibody repertoire-sequencing tool, we 
applied it to study the antibody repertoire of infants and toddlers residing in a malaria endemic 
region of Mali. From an ongoing malaria cohort study
90
, we obtained paired PBMC samples 
collected before and during acute febrile malaria from 13 children aged 3–47 months old (Figure 
3.8 and Table S5). Two of the children were followed for an additional year, giving 15 total 
paired PBMC samples. An average of 3.8 million PBMCs per sample was directly lysed for 
RNA purification. All PBMCs were subjected to MIDCIRS analysis. An average of 3.75 million 
sequencing reads was obtained for each PBMC sample (Table S6). 
For all PBMC samples, sequencing approximately the same number of reads as the cell 
numbers saturates the rarefaction curve (Figure 3.9). IgM accounts for more than 50% of the 
repertoire in infants but reduces to less than 50% in toddlers (Figure 3.10). VDJ gene usage is 
highly correlated for IgM between infants and toddlers (Figure 3.11), demonstrating that the 
same mechanism of VDJ recombination is used to generate the primary antibody repertoire in 
infants and toddlers(Figure 3.11). The diagonal lines in each panel indicate same sample self-
correlation, and the two shorter off-diagonal lines indicate correlations from two time points of 
the same individual. These data recapitulate previous observations in zebrafish that clonal 
expansion-induced differences on the number of reads in each VDJ class can confound the 
highly similar VDJ usage during B cell ontology
31
. In addition, infants and toddlers have similar 
CDR3 length distributions across the three isotypes and both time points (Figure 3.12), 







confirming the previous results that an adult-like distribution of CDR3 length is achieved around 




22Figure 3.8: Sample collection timeline. All pre-malaria blood draws were taken in May, just 
before the start of the rainy season. Acute malaria blood draws were taken 7 days after the onset 
of acute febrile malaria. Unless otherwise indicated (a), all samples were collected during 2011. 





23Figure 3.9: Rarefaction analysis of paired PBMC malaria cohort sequencing libraries. (a) 
Pre-malaria PBMC rarefaction curves (N=15). (b) Acute malaria PBMC rarefaction curves 
(N=15). Raw reads were subsampled to varying depths, and MIDCIRS was used to determine the 
number of unique RNA molecules. All single-read sequences that occurred before subsampling 
were discarded. Single-read sequences that occurred as a results of subsampling were included as 
unique RNA molecules. The number of unique RNA molecules discovered saturated for all 







24Figure 3.10: Antibody isotype distribution for infants and toddlers.  Antibody isotypes were 
assigned based on the portion of the constant region sequenced for infants (A) and toddlers (B). 





25Figure 3.11: Correlation between VDJ usage in paired PBMCs samples (N=15 pairs of pre-
malaria and acute malaria). Correlations weighted by reads. The color bar left of each panel as 
well as in figure legend indicates the sample group: infant pre-malaria (pink), toddler pre-malaria 
(light green), infant acute malaria (maroon), and toddler acute malaria (dark green). Color 
indicates strength of Pearson correlation. The diagonal lines in each panel indicate same sample 




26Figure 3.12: CDR3 amino acid lengths of infants (black, N=6) and toddlers (red, N=9) at 
pre-malaria (top) and acute malaria (bottom) time points, separated by isotype. 
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Both infants and toddlers have unexpectedly high SHM 
SHM is an important characteristic of antibody repertoire secondary diversification due to 
antigen stimulation
94
. Although it has been demonstrated before that infants have fewer 
mutations in their antibody sequences than toddlers and adults, the limited number of sequences 
for only a few V genes does not provide convincing evidence of the levels of SHM in infants
95
. 
A recent study using the first generation of IR-seq showed that two 9-month-old infants averaged 
at least six SHMs in IgM of an average length of 500 nucleotides
83
. These numbers are 
equivalent to, if not higher than, reported SHM rates in IgM sequences from healthy adults day 7 
post influenza vaccination
27
 and are much higher than a low-throughput infant study using a few 
V genes and limited antibody sequences
96
. Owing to the inherent errors associated with the first 
generation of IR-seq as discussed above, it is possible that PCR and sequencing errors had a 
role
83
. In addition, it remains unclear whether infants (< 12 months old) are able to generate a 
significant number of mutations in response to infection, which would demonstrate their capacity 
to diversify the antibody repertoire
97
. 
Here, we show that infants (< 12 months old) and toddlers (12–47 months old) reach an 
unexpectedly high level of SHMs in all three major isotypes, particularly IgG and IgA
98
 (Figure 
3.12a). Although the mutation distributions remain in the low end of the spectrum for IgM, the 
number of mutations is significantly higher in IgG and IgA for both age groups. The threshold 
for the 10% most highly mutated unique RNA molecules is around 10 in infant IgG and IgA 
sequences (Figure 3.12a, infants, right of the blue long vertical lines) and around 20 in toddler 
IgG and IgA sequences (Figure 3.12a, toddlers, right of the blue long vertical lines). To 
minimize any possible inflation of SHMs, we excluded all sequences that were mapped to novel 
alleles, which were identified by both TIgGER
99
 and inspecting IgM sequences (Methods). 
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These putative novel alleles account for 8% of all unique sequences on average. Naive B cells 
from these same patients, sorted as a control, harbor only 0.55 mutations on average, as expected. 
Upon acute malaria infection, the SHM histogram shifts rightward for almost all isotypes in 
almost all individuals (Figure 3.12a, the right shift of pink long vertical line compared to blue 
long vertical line), including infants. These results demonstrate high levels of SHM that exceed 
what have been documented previously
9596,98
. 
SHM load is distinct between infants and toddlers. 
The differences in the shapes of SHM distributions of infants and toddlers, steadily decreasing 
from unmutated for infants in all three isotypes while peaking around 10 for toddlers in IgG and 
IgA (Figure 3.13a), suggest that the total SHM load might reflect the history of interactions 
between the antibody repertoire and the environment, including malaria exposure. As the malaria 
season is synchronized with the 6-month rainy season (Figure 3.8), and > 90% of the individuals 
in this cohort are infected with P. falciparum during the annual malaria season
90
, we 
hypothesized that the SHM load would increase with age. However, we found that the SHM load 
rapidly increases with age in infancy and then appears to plateau around 12 months of age 
(Figure 3.13b). The two-staged trend of SHM load remains for all three isotypes (Figure 3.13b), 
with samples around the transition having the largest variation. Detailed comparisons show that, 
consistent with the two-stage trend, toddlers have a higher SHM load compared with infants for 
all three isotypes at both pre-malaria and acute malaria time points (Figure 3.13c). Although 
there is a significant increase on SHM load upon acute malaria infection in IgM for both infants 
and toddlers, bulk PBMC analysis does not show a significant increase in IgG or IgA, possibly 
because of the already elevated SHM base level. This, along with the two-stage trend (Figure 
3.13b), suggests that 12 months is an important developmental threshold for secondary antibody 
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repertoire diversification: before this threshold, the global repertoire is quite naive but can 








27Figure 3.13: Infants and toddlers are separated into two stages based on SHM load. a). 
Distribution of SHM number for infants (N = 6) and toddlers (N = 9), from whom we had paired 
pre-malaria (blue) and acute (pink) malaria samples, weighted by unique RNA molecules. Blue 
and pink long vertical lines represent the number of mutations above which 10% of sequences 
fall for the respective samples. * and † demarcate samples derived from the same individuals  
65 
 
Figure 3.13 cont. 
followed for two malaria seasons. b) Age-related average number of mutations in pre-malaria 
(blue circle, N = 24, NInfant = 11, NToddler = 13) and acute malaria (pink triangle, N = 15, N-
Infant = 6, N-Toddler = 9) samples, weighted by RNA molecules. Dashed line indicates the age 
boundary for infants (< 12 months old) and toddlers (12–47 months old). c) Comparison of 
average number of mutations for paired infants and toddlers. Pre- (blue) and acute (pink) malaria 
samples separated by isotype; lines connect paired samples (N-Infant,paired = 6, N-Toddler 
paired = 9). Bars indicate means. *P < 0.05, **P < 0.01, N.S. indicates no significant difference 
by two-tailed Mann–Whitney U test (between age groups, dashed lines) or two-tailed Wilcoxon 
signed-rank test (between paired time points, solid lines). Differences in variance were not 
significant by squared ranks test. 
SHMs are similarly selected in infants and toddlers. 
One of the key features of antibody affinity maturation is antigen selection pressure imposed on 
an antibody, which is reflected in the enrichment of replacement mutations
100
 in the CDRs, the 
parts of the antibody that interact with antigens, and the depletion of replacement mutations in 
the framework regions (FWRs), the parts of the antibody responsible for proper folding. The 
unexpectedly high level of SHMs observed in infants prompted us to ask whether those SHMs 
have characteristics of antigen selection, as seen in older children and adults. As previous studies 
have shown that infants have limited CD4 T cell responses and neonatal mice exhibit poor 
germinal center formation
87
, we hypothesized that infant antibody sequences would display 
weaker signs of antigen selection.  
Here, we use a recently published tool, BASELINe
101
, to compare the selection strength. 
BASELINe quantifies the likelihood that the observed frequency of replacement mutations 
differs from the expected frequency under no selection; a higher frequency implies positive 
selection and a lower frequency implies negative selection, and the degree of divergence from no 
selection relates to the selection strength. Surprisingly, despite infants harboring fewer overall 
mutations, these mutations are positively selected in the CDRs and negatively selected in the 
FWRs in both IgG and IgA (Figure 3.14b, c, e, f). Contrary to the hypothesis that infants would 
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have a lower selection strength than toddlers, for both IgG and IgA, infants actually have a 
higher selection strength at both pre-malaria and acute malaria time points (Figure 3.14). The 
lower selection strength in infant IgM sequences at the pre-malaria time point is significantly 
higher during acute malaria infection (Figure 3.14a, d, CDR black curves between two time 
points, P < 0.0001 (numerical integration, as previously described)), suggesting that the 
significant increase in SHM is antigen-driven and selected upon. To compare with a large 
amount of historical adult data, we calculated replacement to silent mutation ratios (R/S ratios), 
which are about 2-3:1 in FWRs and 5:1 in CDRs for both infants and toddlers (Table S6). These 
results are similar to adults
100,102–104
, and much higher than what has been reported for children 
previously using a very limited number of sequences
105
. We also noticed that R/S ratio in the 
FWRs of IgM was much higher in infants, contrary to the BASELINe results, which highlights 
the importance of incorporating the expected replacement frequency when considering selection 
pressure. These results suggest that as an end result of interactions between antigen selection and 
SHM, the degree of antibody amino acid changes is comparable in infants, toddlers, and adults. 





28Figure 3.14: Antigen selection strength comparisons between infants and toddlers. 
Selection strength distributions, as determined by BASELINe
101
, were compared between infants 
(black) and toddlers (red) for PBMCs from pre-malaria (a–c) (N-infant = 6, N-toddler = 9) and 
acute malaria (d–f) (N-infant = 6, N-toddler = 9) time points, separated by isotype: a, d IgM; b, e 
IgG; and c, f IgA. Selection strength on CDR (CDR1 and 2, top half of each panel) and FWR 
(FWR2 and 3, bottom half of each panel) for unique RNA molecules was calculated. CDR3 and 
FWR4 were omitted due to the difficulty in determining the germline sequence. FWR1 for all 
sequences was also omitted because it was not covered entirely by some of the primers. P value 
calculated as previously described
101
. 
Antibody Lineage diversify upon acute malaria 
One key feature distinct antibody with TCR is ability of somatic hypermutation, which are 
random mutations on the receptor sequences. The exhaustive sequencing data obtained by 
MIDCIRS offers the possibility to reconstruct clonal lineages that trace B cell development. 
Clonal lineages contain different species of unique antibody sequences that could be progenies 
derived from the same ancestral B cell, which are normally organized as a ‘tree’ format
32
. B cell 
clonal lineage analysis has been used to track affinity maturation and sequence evolution of HIV 
broadly neutralizing antibodies
106,107
. The structure of antibody clonal lineage provides another 
way to quantify antibody repertoire and its structure serves as a molecule clock to understand 
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how one antibody lineage is evolving. We constructed all the lineages of the antibody repertoires 
with a pre-determined threshold
32
 (Figure 3.15a) and compared the clonal expanded lineages 
before and after malaria season (Figure 3.15b). Results show upon acute malaria infection, the 
fraction of non-singleton lineages increases in both infants and toddlers, which hints antibody 
lineages get expanded due to malaria infection. 
 
29Figure 3.15: Lineages from malaria samples. a). Structure of one example lineage. Each node 
is a unique RNA molecule species. The height of the node corresponds to the number of RNA 
molecules of the same species, the color corresponds to number of nucleotide mutations, and the 
distance between nodes is proportional to the Levenshtein distance between the node sequences, 
as indicated in the legend above each lineage. All unlabeled nodes share the isotype with the root. 
b). The non-singleton lineage percent (lineages comprises at least two RNA molecules) between 
infants and toddlers at pre-malaria (blue) and acute (pink) malaria. *P < 0.05 by two-tailed 
Wilcoxon signed-rank test (between time points, solid lines); N.S. indicates no significant 






3.2.3 Materials and Methods 
Preliminary read processing 
Raw reads from Illumina MiSeq PE250 were first cleaned up. Only reads that exactly matched 
the corresponding library indices were included for further processing. The end of each raw read 
was trimmed such that all bases had a quality score of 25 or higher.  Reads 1 and 2 were merged 
using the SeqPrep tool (https://github.comjstjohn/SeqPrep). The merged reads were filtered with 
specific V-gene and constant region primers to determine immunoglobulin (Ig) sequencing reads. 
The primers were then truncated from the reads. The retained reads were further truncated to 
320bp for the Naive B cells in method verification experiments and 330bp for samples from 
malaria cohort.  
MID sub-group generating 
Raw reads were split into MID groups according to their 12 nucleotide barcodes. For each MID 
group, quality threshold clustering was used to cluster similar reads. This process groups reads 
derived from a common template RNA molecule together while separating reads derived from 
distinct RNA molecules. A Levenshtein distance of 15% of the read length was used as the 
threshold. This was calibrated using RNA controls with known sequences. For each sub-group, a 
consensus sequence was built based on the average nucleotide at each position, weighted by the 
quality score. In the case that there were only two reads in an MID sub-group, we only 
considered them useful reads if both were identical. Each MID sub-group is equivalent to an 
RNA molecule. Next, we merged the entire identical consensus to form unique consensus 
sequences, or unique RNA molecules, which were used to estimate the diversity and assess the 
sequencing depth in rarefaction analysis 
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Error rate calculation 
The difference between the consensus sequence for an RNA molecule and the raw reads 
associated with it represent the errors generated in either PCR or sequencing. The error rate can 







where Diff(i,I) is the Levenshtein distance between read i and the consensus sequence in MID 
sub-group I, NI is the number of reads in MID sub-group I, and L is the read length.  
In order to estimate the improved error rate using MIDCIRS, we equally divided the raw 
reads from one library into two datasets. The same MID sub-group generating process was 
performed on both datasets. By comparing the differences between the consensus sequences with 
identical MID between these two datasets, we can calculate the improved error rate for using 
MID sub-groups as: 
ErrorRate(MID) =
∑ Diff(I, J)I,J × NI
∑ NII × L
 
,where Diff(I,J) is the Levenshtein distance between the consensus I and consensus J which have 
the identical MID, NIis the number of reads in MID sub-group I, and L is the read length. 
VDJ definition and mutation counts 
As described in previous work, similar methods were used to define the V, D, and J gene 
segments for all sequences
31
.  From the International ImMunoGeneTics information system 
database (IMGT, http://www.imgt.org/textes/vquest/refseqh.html)
108
, human heavy chain 
variable gene segment sequences (249 V-exon, 37 D-exon and 13 J-exon) were downloaded. 
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Each unique sequence was first aligned to all 249 V gene alleles. The specific V-allele with a 
maximum Smith-Waterman score was then assigned. In some cases, newly identified germline 
alleles, defined either by TIgGER or our method (below), were added to the template sequences. 
J-segments and D-segments were then similarly assigned. The number of mutations from 
germline sequence was counted as the number of substitutions from the best aligned V and J 
templates as previously described
29
. The CDR3 was omitted due to the difficulty in determining 
the germline sequence. The germline sequences of V, D, and J gene segments were grouped by 
combining similar alleles into families using IMGT designation in VDJ correlation plots. In total, 
58 V, 27 D, and 6 J families were used. 
Novel allele detection 
To address the possibility of novel germline alleles inflating the observed number of mutations, 
new germline alleles were assembled.  In short, IgM sequences for each subject were aligned and 
assigned to the traditional V-gene alleles in the IMGT database. If novel alleles exist in subjects, 
parts of unique RNA sequences will be assigned as mutations when they are actually derived 
from differences between novel and traditional alleles. The ratios of unmutated unique RNA 
molecules to those with one, two, three and four mutations compared to the IMGT germline were 
determined, and if any were found to be less than 2 to 1, the alleles were flagged for further 
inspection.  Unique RNA molecules were used to minimize the contributions of clonal expansion, 
and IgM sequences were used to minimize the contributions of somatic hypermutation.  
Sequences within flagged alleles were then aligned to the closest IMGT germline to determine if 
the mutations are truly polymorphisms.  When identical mutation patterns were observed in a 
minimum of 80% of all sequences in a flagged allele family, it was deemed a novel germline 
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allele.  For subjects with sorted NaiBs, novel alleles were generated from the NaiB BCR 
sequences to complement those found in the bulk IgM sequences.   
TIgGER was used as previously reported as another method to discover novel alleles 
109
.  
TIgGER compares the mutation rate at a specific position to the overall number of mutations for 
sequences within the same assigned V-gene allele.  Outliers within the low mutation region 
suggests the existence of a novel allele, and the shape of the curve can effectively distinguish 
between individuals homozygous and heterozygous for the novel allele.   
Our new method and TIgGER have a 90% percent overlap in newly identified alleles.  
Discrepancies between the two methods were treated with a conservative estimation on the 
number of SHM, meaning we liberally included novel alleles as part of the germline gene 
segments.  Non-overlapping novel alleles were manually inspected, and the union of novel 
alleles detected by TIgGER and our method was included as part of the germline gene segments. 
Sequences mapped to these novel alleles were excluded from our analysis, which accounts for an 
average 8% of all sequences. 
Translation from nucleotide to amino acid sequences 
Nucleotide sequences were translated into amino acid sequences based on codon translation. The 
unique RNA sequences were inputted to IMGT High V quest to translate into amino acid 
sequences. The boundary of the CDR3 is defined by IMGT numbering for Ig and two conserved 
sequence markers of ‘Tyr-(Tyr/Phe)-Cys’ to ‘Trp-Gly.’ CDR3 length was determined according 




The selection pressure was evaluated via BASELINe
99
. The unique RNA molecules of PBMC, 
populations were inputted to BASELINe and compared with the closest IMGT germline alleles. 
The observed number of replacement and silent mutations were compared with the expected 
number of mutations for the assigned germline sequence. A selection strength as measured by 
the probability density function (PDF) was generated using BASELINe
99
 to indicate the direction 
and degree for CDR (CDR1 and 2) and FWR (FWR2, and 3) regions for each unique RNA 
molecule first, then combined for each individual, and then further combined for each of the two 
groups, infants and toddlers. The PDFs were plotted and compared between infants and toddlers. 
The associated P values comparing two group PDFs were calculated using BASELINe. Samples 
with 5,000,000 PBMCs were subsampled to 120,000 RNA molecules. Samples with fewer 
PBMCs were subsampled to proportionally fewer RNA molecules according to the PBMC 
number. 
Replacement/Silent mutation 
According to the amino acid sequence translation results and V/D/J gene templates alignment 
results, we counted the number of nucleotide mutations resulting in amino acid substitutions 
(replacement, R) or no amino acid substitutions (silent, S) in FWR region (FWR2 and  3) and 
CDR region (CDR1 and 2). The number of silent and replacement mutations was averaged in 
each age-group (Infant and Toddler) and the ratio for silent vs. replacement mutation was 
calculated. The CDR3 and FWR4 were omitted due to the difficulty in determining the germline 
sequence. FWR1 for all sequences was also omitted because it was not covered entirely by some 
of the primers. Samples with 5,000,000 PBMCs were subsampled to 120,000 RNA molecules. 
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Samples with fewer PBMCs were subsampled to proportionally fewer RNA molecules according 
to the PBMC number. 
VDJ usage correlation 
The correlation of VDJ usage between infants and toddlers were calculated with Pearson 
Correlation Coefficient as the following formula: 
corr =
∑ (Xvdj−< X >
v={V},d={D},j={J}
)(Yvdj−< Y >)
√∑ (Xvdj −< X >)




vdj refers to the combination of one v allele family from 58 V gene allele families ({V}), one 
d allele family from 27 D gene allele families ({D}), and one j allele family from 6 J gene allele 
families ({J}). For the reads weighted correlation, Xvdj  and Yvdj  refer to the fraction of reads 
assigned to the respective vdj combination for subjects X and Y, respectively. < X > and < Y > 
are the average reads across all vdj combinations, i.e. 1/9396, where 9396 is the total possible 
number of vdj allele family combinations. For the lineage weighted correlation, these parameters 
refer to the fraction of lineages for each vdj allele family combination.  Samples with 5,000,000 
PBMCs were subsampled to 120,000 RNA molecules. Samples with fewer PBMCs were 
subsampled to proportionally fewer RNA molecules according to the PBMC number. 
Lineage structure construction and visualization  
Representative lineages were selected to visualize the lineage structures and the evolution of 
antibody sequences. Lineage structures were generated using COLT (software can be 
downloaded here: http://www.cs.wright.edu/~keke.chen/software/colt.zip) and validated 
manually. We implemented a lineage visualization tool, COLT-Viz. In short, COLT considers 
constraints (e.g., isotype and timepoint) along with mutational patterns to build lineage trees. The 
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height of each node is proportional to the number of RNA molecules associated with the unique 
sequence (size), the color of each node relates to the number of SHMs, and the distance between 
nodes is proportional to the Levenshtein distance between the node sequences. 
Code availability  
References or links for all software tools used are listed in the relevant “Methods” sections. All 
other relevant data are available from the authors. 
Data availability  
Sequencing data that support the findings of this study have been deposited in dbGaP with the 














About 13,000 children under 1 year old die every day worldwide
110
, and most of these deaths are 
caused by infection
87
. It has long been recognized that children’s immune systems are immature 
at birth and require time to develop to provide protection against pathogens or respond to 
vaccines. However, few studies have focused on children’s antibody repertoire development, 
diversification, and response to infection. Knowledge in this area holds great interest to vaccine 
development and vaccination strategy design. This is especially urgent for malaria, as it still kills 
about half a million children each year
111
, and the most advanced malaria vaccine confers only 
partial, short-lived protection in African children
112
. 
Previous studies showed that there was evidence of SHM and antigen selection in infants 
8 months of age or older by examining a few V-gene alleles
95
. However, it is not clear how 
widespread SHMs are in infant antibody repertoires and to what degree SHMs can be introduced 
in response to an infection. By using a comprehensive and unbiased analysis, here we show that 
infants as young as 3 months old can have 10% of sequences with five or more mutations, and 
they can further introduce mutations upon an acute febrile malaria infection to well over 20 SHM 
per 270 nt heavy chain V region. Compared with toddlers, there is a separation on SHM load 
around 12 months: this number gradually increases before 12 months and stays at a plateau after 
that regardless of repeated malaria incidents. Consistent with this trend is the similar pattern 
observed in the increase in the percentage of memory B cells and corresponding decrease in 
percentage of naive B cells with age: both plateaued after 12 months of age. Accordantly, SHM 
load in IgM, IgG, and IgA correlates with the percentages of naive and memory B cells. 
Surprisingly, regardless of the lower mutation load in infants, their mutations are similarly, if not 
more strongly, selected as those of toddlers, suggesting that the molecular machineries and other 
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cellular components involved in antibody selection are already developed in infants. In future 
analyses, it will be of interest to tease out the mechanistic contributions to a two-stage increase 
of average mutation number, in particular, the role of T cell help and germinal center formation. 
Regardless of these detailed mechanisms, it is clear infants can perform antibody selection as 
well as toddlers and adults, which provides some assurance of the effectiveness of vaccination in 
young children. 
In summary, we systemically studied the antibody repertoire in malaria-exposed infants 
and toddlers and discovered several aspects of repertoire development, diversification, and 
capacity to respond to an infection that were not known before, which provides not only new 
parameters and approaches in quantifying vaccine efficacy beyond traditional serological titer 
but also venues for future studies of detailed molecular and cellular mechanisms that drive 











Chapter 4: LiMPETs-Linear programming based Motif Pick and Enrichment 
analyze for Tcrs 
 
4.1 INTRODUCTION 
One main challenge of engineering T-cell receptors (TCRs) for immunotherapy is to correctly 
identify TCR sequences that can recognize certain pathogen associated epitope. Because of its 
importance, growing efforts have been made in this area. Several experiment techniques have 
been developed for TCR antigen-binding specificity measurement
113
(e.g., Fluorescent pMHC 
tetramer, CyTOF with isotope-labeled pMHC tetramers, etc), but all the techniques suffer from 
low throughput.  
 Computational methods for predicting TCR specificity is attractive, since it’s cheap and 
easy to be high-throughput. TCR recognizing its antigen peptide through protein-protein 
interaction, so computational methods for protein structure modeling have been applied to 
predict TCR-peptide binding affinity 
114
.  A routine way of modeling protein structure is to first 
model an initial structure (either by homology modeling or ab initio modeling), then use 
Molecule Dynamics (MD) simulation to refine the structure. However, there are several 
challenges to apply this for TCR-peptide complex modeling: 1). Homology modeling requires 
template structure of a very similar sequence, while TCR is highly diverse, current available 
crystal structures covers only a very small proportion of the whole repertoire; 2). The most 
important region to determine TCR antigen specificity are the Complementary Determining 
Regions (CDR1, CDR2, CDR3), since these regions contact directly to peptides. However, these 
regions normally adopt a linear loop structure, which means they are quite flexible and hard to 
model. The accuracy now is still unsatisfied and the prediction accuracy of the loops drops when 





);  3). Correctly model TCR itself is already hard, while to model the TCR-peptide 
complex is even harder, since conformation of those contact loops will change before and after 
binding to peptides
116
. 4). Even though the computation efficiency is growing dramatically (e.g., 
High-performance computing, GPU, etc.), MD simulation is still computationally expensive and 
to be used for screening such the diversified TCR repertoire is challenging. 
It will be ideal if TCR’s binding specificity can be predicted directly from its sequence. 
Machine learning seems to be a promising way, given its great power and capability to model 
even very complicated distributions. However, to train machine learning model requires 
significant amount of data, especially when the problem itself is complicated. A curated database 
has been designed to record published experimentally validated TCR antigen specificity
117
, 
which provides valuable resource for TCR-antigen binding specificity research. However, these 
accumulated TCRs can still only cover a very small proportion of the enormous diversity of TCR 
repertoire. Also data collected in this curated database does not consider cross reactivity between 
TCRs and peptides. 
Although TCR sequences are quite diverse, the specificity of each TCR is determined by 
the interaction between TCR with peptide-major histocompatibility complex (pMHC), TCRs 
recognize the same antigen must share some similarity. This similarity should be able to detected 
by computational methods and possibly been used for predicting TCR specificity. Researchers 
have shown conserved motifs are shared by TCRs of the same specificity at positions of high-
antigen-contact probability 
118
. Glanville et al. developed GLIPH 
17
, which can identify 
conserved motifs from TCRs CDR3 sequences of the same specificity. GLIPH determines 2-
4mers continuous amino acid sequences (motifs) that significantly enrich in certain antigen 
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specific TCR group by comparing to naive TCRs group. Candidate motifs are extracted from the 
CDR3 region of TCR beta chain.  
Here, we are reporting another tool, named LiMPETs, which has similar function of 
selecting antigen specific motifs from a group of antigen specific TCRs. Same as GLIPH, we 
focus only on TCR beta chain CDR3, since this is the most important specificity determine 
region (most antigen-contact), the most variable region
17
 and so with the most data available
117
.  
LiMPETs forms the process of selecting antigen specific motifs as a least absolute deviation 
(LAD) problem in multiple linear regression, and solves the optimization problem with Mixed-
Integer Linear Programming (see methods). LAD is well known for its robustness to outliers and 
easy to interpret
119
, and find its applications in bioinformatics for variable (feature) 
selection
120,121
. Here, we implement LAD to select antigen specific motifs and shows LiMPETs 
is more accurate and is more reliable than GLIPH. Also, compared to GLIPH, LiMPETs can 
easily be generalized to multiple specificity groups and can take TCR cross-reactivity (i.e., same 
TCR recognize multiple antigens or same antigen recognized by multiple TCRs) into 
consideration. Also, LiMPETs is developed under the popular R circumstance as a package, so 





4.2 MATERIALS AND METHODS 
4.2.1 Problem formulation 
Given a set of TCRs with known antigen specificity, LiMPETs tries to identify motifs enriched 
in the TCR set by comparing with another set of naive TCRs. This process of selecting motifs is 
formed as solving the following LAD problem with linear programming method. 
 
30Figure 4.1: Schematic of LiMPETs model 
As shown in Figure 4.1, our linear model contains 4 matrices/vectors: 
a). Occurrence matrix(A): A matrix records whether one motif exists in the CDR3 
sequence of a TCR or not. 1 means the motif can be found in the TCR, while 0 means not; 
b). Weight vector(W)/diagonal weight matrix(D): A vector (W) given prior weights for 
all motifs, ‘W’ is user defined, it can either be all-ones vector(i.e., no prior bias on the motifs), or 





etc.). In this work, we defined a weight vector based on the frequency of motifs within the naive 
TCR dataset, which will be described later. The diagonal weight matrix(D) is a diagonal matrix 
with all the elements on the diagonal equal to W, i.e., D=diag(X). 
c). Specificity vector(Y): A vector records whether one TCR is from antigen specificity 
TCR group or from naive TCR group. 1 means the TCR is from antigen specificity TCR group, 
while 0 means from naive TCR group; 
d). Importance vector(X): A vector needs to be solved by linear programming algorithm. 
The values represent how significant one motif is enriched in the antigen specificity TCR group; 
Given ‘m’ sequences, and ‘n’ motifs, the linear model is: 
𝐴𝐷𝑋 = 𝑌                                                                                             (1) 
,where A is a mxn binary matrix, D is a nxn diagonal matrix, X and Y are nx1 vectors. 
Given the CDR3 sequence of a TCR, a window of 3 or 4 amino acids (AAs) slides across 
the CDR3 sequence, and the occurrence of motifs within the TCR are recorded in matrix A, 
while its antigen specificity is recorded in the vector Y. 
After encoded the motif occurrence and antigen specificity, LiMPETs solves for ‘X’ by 
minimizing: 











The advantage of minimizing on the L1-norm is its robustness to outliers 
123
 and sparsity 
of residuals after optimization 
124
. We need the robustness because our control set is from naive 
TCRs instead of real true negative TCRs. The sparsity of residuals will prompt lots of 
insignificant residuals (i.e residuals close to 0), through which the values in ‘X’ will be either 0 
or larger than 1. 




,        𝑠. 𝑡.  𝑋𝑗 ≥ 0, 𝜀𝑖 ≥ 0, (∑(𝐴𝐷)𝑖𝑗𝑋𝑗
𝑛
𝑗=1
) − 𝑌𝑖 ≤ 𝜀𝑖 , (∑(𝐴𝐷)𝑖𝑗𝑋𝑗
𝑛
𝑗=1
) − 𝑌𝑖 ≥ −𝜀𝑖 
                                                                                                                                                                                       
(3) 
4.2.2 Weight vector generation 
The weight vector can be any prior information for each motif, in this work we designed a 
weight vector by analyzing the naive CD8+ TCR dataset and adopted ‘markov chain’ 
125
 to 
calculate the prior weight for each motif: 
1). The ‘initial state probability’ (π) of the markov chain was calculated by counting the 
frequency of each amino acid within the CDR3 region, which is a vector of 20 elements. The 
‘transition matrix’(T) was also calculated by counting the frequency of each possible transition 
between two adjacent amino acids in naive CD8+ CDR3 region, which is a 20x20 matrix. 
2). For each motif S, a probability associated can be calculated using the ‘initial state 
probability’ (π) and ‘transition matrix’(T): 
𝑃𝑆 = 𝜋𝑆1 ∗ ∏ 𝑇(𝑆𝑘,𝑆𝑘+1)
𝑛
𝑘=2                                                                          (4) 
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 amino acid of motif S, n is the 
length of S. Ps represents the probability of generate given motif ‘S’ by random. 
3). The probability for all motifs of different lengths can be calculated using equation (4). 
In order to normalize and compare motifs of different lengths, we further normalize the 
probability with the motif length: 
𝑃𝑁 = 1 − 𝑃𝑠
1
𝑛                                                                                    (5) 
,where PN is the normalized weight for given motif ‘S’, while n is the length of S. 
4.2.3 Implementation 
 




Figure 4.2 shows the workflow of LiMPETs, which contains four steps: 
a). Given a set of TCR CDR3 sequences, generate the ‘Occurrence Matrix’ by record 
whether one motif exist within a TCR; generate ‘Specificity Vector’ by record whether this TCR 
is antigen specific or from the naive control group; 
b). To accelerate the following steps, LiMPETs filters out motifs exist within only one 
TCR; 
c). Solve the linear programming problem in Equation (3) with the Open Source Mixed-
Integer Linear Programming System lp_solve 
126
; 
d). To evaluate the associated significance (p-value) of each motif, LiMPETs adopts chi-
square test, Benjamini-Hochberg adjustment (BH) 
127
 was used to adjust p-value for multiple 
testing. In this work, motifs with p-values smaller than 0.01 were selected as significant motifs. 
The resulting motifs and associated p-value can be utilized in different ways, e.g., it can 
be used to identify antigen specificity groups from T cell receptor repertoire as GLIPH does; it 
may also be used to predict the specificity of TCRs by evaluating whether these TCR contain any 









4.3.1 Determine an appropriate sample size for naive TCR dataset 
In order to tune and test our model, we designed a dataset (Dataset 1) contains TCRs specific to 
one of the 3 antigen shown in Table 4.1 by gathering data from Glanville et al.
17
, Dash et al.
128
. 
Since there are siginficant fewer TCRs for pp65, we also included a random sample of pp65-
specific TCRs within VDJdb(downloaded on 02/02/2018)
117
 to even the data size. Only TCR-
beta sequences have been used for the testing. We chose these 3 antigens because they were 
associated with the most TCRs across our data sources. We also included the naive CD8+ TCRs 
in Glanville et al.
17
 as negative control dataset. 
1Table 4.1: TCRs contained in Dataset 1 
Antigen Peptide Species HLA Number of unique CDR3s 
BMLF1 GLCTLVAML 
Epstein-Barr 
virus(EBV) HLA-A*02 748 
M1 GILGFVFTL Influenza(FLU) HLA-A*02 697 
pp65 NLVPMVATV Cytomegalovirus(CMV) HLA-A*02 682 
Naive N/A N/A N/A 27,845 
 Feature(variable) selection on imbalanced dataset is a challenge problem in data mining 
research
129
, but very common in real medical applications
130
, where normally negative controls 
overwhelmed the whole dataset. One epidemiological case-control study propose a ratio of 4:1 
between control versus cases
131
. Here, we used 10-fold cross-validation to determine an 
appropriate control dataset size. The results are shown in Figure 4.3. We chose the negative 
dataset to be 50 folds of the positive dataset, if the number of desired controls is more than the 




32Figure 4.3: Coverage and Accuracy of LiMPETs with different negative control dataset 
size. With the increase of control (naive) dataset size, the accuracy of LiMPETs prediction 
reached to plateau. 
4.3.2 LiMPETs is more robust than GLIPH  
Although more and more measurement have been performed and TCRs with known antigen 
specificity have been gathered,  due to the low throughput of current experiment and the huge 
diversity of TCR repertoire, TCRs with known specificity are still very limited and  imbalanced 
(https://vdjdb.cdr3.net/).  In order to make use of current limited dataset, a tool with robust 
performance on small dataset is essential.  To test the robustness of LiMPETs and GLIPH, we 
gradually down sampled Dataset 1 from 90% to 10% as training dataset, while use the remaining 
TCRs as test dataset.  Motifs and their specificity identified from training dataset can be used to 
predict the specificity in the test dataset (i.e., if one sequence in test set contains certain motif, 
then its specificity will be predicted to be the same as the motif). Coverage (percentage of TCRs 
predicted) and accuracy (the percentage of correct predictions) of the specificity prediction can 
be compared between the two methods.  
Figure 4.4 shows the testing results of LiMPETs versus GLIPH on different sub-sample 
size. Overall, LiMPETs performs more accurate than GLIPH, but GLIPH’s accuracy drops 
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significantly when the dataset size becomes small (~200 total TCRs and ~70 for each antigen 
specificity group).  GLIPH identifies significant motifs by repeat sampling from naive dataset of 
the same number of TCRs in the ‘antigen specific group’, and a p-value will be calculated by 
counting the frequency of samples with certain motif more enriched/frequent than the ‘antigen 
specific group’. This numerical way is essentially trying to estimate the frequency of given motif 
in the naive TCR dataset and calculated the p-value based on the sampling distribution. However, 
when the sample size becomes smaller, the variance of the sampling distribution will become 
larger, which means the numerical p-value will become less accurate in small samples. We also 
compared LiMPETs’ performance with/without motif weight, adding the weight did not 
significantly increase accuracy, but increased coverage of LiMPETs on small dataset.  
 
33Figure 4.4: Comparison of LiMPETs versus GLIPH on different sample size. LiMPETs is 




4.3.3 LiMPETs is more generalizable than GLIPH  
GLIPH identify significant motifs by comparing the frequency of one motif with 1,000 random 
sampled sets from naive TCR dataset. The way of doing this has an intrinsic drawback when 
given one set of similar sequences (Figure 4.5), multiple significant motifs can be identified from 
the same sequence. However, the crystal structure analysis show the ‘contact residues with 
antigen peptide are typically three to four amino acids in length and usually contiguous’ 
17
, so the 
identified significant motifs cannot all be true (false positive). The design of LiMPETs enforced 
it to identify only one significant motif for each sequence, which is more stringent than GLIPH 
and will output fewer motifs, but we argue the identified significant motifs should be more 
generalizable to novel TCRs. GLIPH will output more motifs but contain more false positive 
ones, and it’s highly possible those false positive motifs will cover TCRs of other antigen 
specificity. 
 
34Figure 4.5: Given one set of CDR3 AA sequences, GLIPH may identify multiple significant 
motifs from the same sequence. 
 To test whether our expectation is true, we applied both methods on the TCRs collected 
within VDJdb. We only focus on human CD8+ TCR beta-chain CDR3 and we require each set 
of certain antigen specific group to contain at least 100 unique TCRs. Based on this criteria, we 
selected 14 TCR groups with various antigen specificity and MHC restriction (Dataset 2, Table 
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S8). Each ‘antigen-specific group’ can further be divided into sub-groups based on their source 
(i.e., original publications).  
 
35Figure 4.6: Workflow of testing on VDJdb database. Each time a subset of TCRs with the 
same specificity from one publication is retained as test dataset and the other TCRs were used as 
training set (i.e., ‘leave one publication out’ test). 
To test both methods, we repeated the following steps (Figure 4.6):  
1). For each sub-group (TCRs originated from the same publication), if it contains >100 
TCR sequences, then it will be removed from Dataset 2, the remaining dataset will be used as 
‘training dataset’, while the removed set will be retained as ‘test dataset’;  
2). If the training dataset still has >100 TCR sequences for each antigen-specific group, 
then we apply both methods (LiMPETs and GLIPH) on each antigen-specific group to identify 
significant motifs, and use the motifs identified to test on the ‘test set’.  
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In total, we identified 9 test groups, 8 of which are HLA-A*02 restricted (Table S9). 
Since for the same group within the training dataset, LiMPETs and GLIPH will identify different 
number of significant motifs. Also the number of sequences within each test dataset varies a lot. 
In order to compare the enrichment of the two sets of motifs within eac test dataset, we defined 
an ‘enrichment score’ calculated as a numerical p-value: repeatedly sample the same number of 
motifs from the naive TCRs (1,000 times), and count the frequency (p-value) that the sampled 
motif sets covered more sequences than the identified ‘significant motif sets’. Then the 
enrichment score is calculated as: 
𝑆 = −𝑙𝑜𝑔10𝑃                                                                                 (6) 
, where P is the numerical p-value, and S is the designed Enrichment score. 
 Figure 4.7 shows the visualization of enrichment score for each test dataset across all the 
antigen specificity groups within the training datasets. Clearly, motif set identified by GLIPH for 







36Figure 4.7: Heatmap visualization of enrichment score. The black boxes represent true 
antigen specificity, which means the row and column are from the same antigen specificity group 
and restricted by the same MHC. 
If we treat this as a multi-class classification problem, then the ROC curves for the cross-
validation test described above are shown in Figure 4.8. Strikingly, both methods perform quite 
well, with Area Under Curve (AUC) higher than 0.9, LiMPETs shows even higher classification 




37Figure 4.8: ROC curve for LiMPETs and GLIPH on Dataset 2. Legend shows the Area 
under curve (AUC) of both methods. 
4.3.4 LiMPETs eliminates more false positive than GLIPH 
The test results across VDJdb shows that LiMPETs has less false positive compared to GLIPH, 
however, our ROC curve analysis assume there is no cross-reactivity between different antigen 
specific TCR groups. It’s hard to control TCR cross reactivity in Dataset 2, because VDJdb is a 
curated database gathering data from previous publications, which means we can only know 
certain TCR will bind to certain peptide, but we do not know whether this TCR will or will not 
bind to other peptides.  
To have a better controlled result, we experimentally validated a set of TCRs (Dataset 3) 
which are HLA-A2 restricted and specific to M1 peptide (GILGFVFTL)  but not specific to 
HCV peptide(CINGVCWTV) (data not published). This set of TCRs contains 438 unique CDR3 
sequences, within which we counted how many TCRs contain significant motifs identified from 
Dataset 2 for M1 and HCV. Table 4.2 summarizes the performance of LiMPETs versus GLIPH, 
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both methods cover similar number of M1 specific TCRs within Dataset 3, but 7 TCRs also 
contain HCV specific motifs identified by GLIPH while zero TCRs contained LiMPETs HCV 
motifs. Although the number does not vary a lot, considering our sampling space is whole human 
TCR repertoire, this difference means a lot. The associated numerical p-value has also been 
calculated as described above (Equation 6), HCV specific motifs identified by GLIPH is almost 
significant enriched in our experiment validated M1 specific TCRs. The numerically calculated p 
value is 0.056, which means only 56 out of 1000 times that a random set of motifs will cover 
more than 7 sequences within Dataset 3 M1 specific TCRs. Another point worth to mention is, 
LiMPETs identified less than one half of significant motifs compared to GLIPH (Table 4.3) but 
the coverage are similar, which proves LiMPETs is more stringent but the significant motifs 
identified are more generalizable. 
2Table 4.2 Number of TCRs in Dataset 3 contain significant motifs identified from Dataset 2 
(with numerical p-value). 
Number of TCRs in 
Dataset 3 M1 HCV 
LiMPETs 214(0.005) 0(1) 
GLIPH 213(0.009) 7(0.056) 
3Table 4.3 Number of significant motifs identified from Dataset 2 by both methods 
Number of Motifs M1 HCV 
LiMPETs 55 14 





Computationally predicting TCR antigen specificity is attractive given its wide application in 
basic research and clinical usage (e.g., cancer immunotherapy).  Traditional way of 
computational modeling for protein-protein interaction is not accurate enough, due to the 
flexibility of the loop contact region 
115
, the lacking of homology modeling templates and the 
conformation change before/after TCR bind to pMHC 
116
. Also, the high computational cost 
limits its usage in high-throughput applications. Machine learning (ML) algorithms are powerful 
and potentially can be used for TCR specificity prediction. However, the fundamental step of 
applying ML methods is feature engineering, which is to find an appropriate feature set for the 
algorithms. In this work, we adopted a linear model which can automatically select features 
during optimization. Tests of LiMPETs on both public and in-house data show its advantages 
compared to current existing method.  
 We designed the penalty function as L1-norm format instead of L2-norm. The L2-norm 
format is well known as least square regression, which is well studied and has explicit solution. 
Within an overdetermined system (i.e., number of observations > number of features, as in our 
model), methods (e.g., Singular Value Decomposition based
132
) have been developed to 
approximating the least square solution. However, we decided on choosing L1-norm because its 
robustness to outliers (erroneous measurement) while L2-norm’s solutions are sensitive to 
outliers. Figure 4.9 shows the comparison of accuracy between using L1-norm versus L2-norm. 
Also, the sparsity of L1-norm penalty function will prompt large number of residuals close to 0, 
which can be used for automatic motif selection. The least square regression was solved by 
Singular Value Decomposition (SVD), and the most weighted motifs (same number of motifs as 




38Figure 4.9: LiMPETs accuracy compared with Least square regression. X-axis represents 
different input sample size from Dataset 1.  
 Besides the accuracy and robustness of LiMPETs, the framework we proposed here can 
be easily generalized: 1). By introducing dummy variable, the ‘Specificity vector’ term can be a 
binary matrix instead of a vector, through which TCR cross-reactivity (i.e., same TCR recognize 
multiple antigens) information can be included for motif selection; 2). Current model encode the 
‘Occurrence Matrix’ as binary matrix, although prior information can be incorporated by the 
‘Weight vector’, continuous variables may perform better; 3). Current model does not consider 
interactions between motifs, cross terms can be added in the linear model in order to generalize it. 
 LiMPETs adopted linear programming solver to solve for the ‘Importance vector’, which 
requires significant amount of computational memory to manipulating matrices, however since 
our system is sparse, solvers/algorithms
133
 more efficient for sparse matrices should perform 
faster. In this work, we used chi-square test at the final step to calculate an associated p-value, 
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however chi-square test is not reliable for low-frequency terms 
134



















Chapter 5. Conclusions and Future studies 
We developed MIDCIRS computational pipeline for correctly measuring immune repertoire, 
together with wet lab experimental design, we showed MIDCIRS’ high accuracy, high coverage 
and wide dynamic range compared with other tool/pipeline. We detailed analyzed MIDCIRS 
performance measured with various metrics to prove MIDCIRS advantages. However, as we 
demonstrated in Chapter 2, the efficiency of current MIDCIRS is only ~30% and this is mainly 
due to RT/PCR efficiency drops, design of more efficient primers and experimental procedures 
will help to improve MIDCIRS’ efficiency. 
Having demonstrated the benefits of MIDCIRS, we applied MIDCIRS to real world 
problems to study antigen driven immune response. We used MIDCIRS to measure the antibody 
repertoire from malaria-experienced individuals and found unexpected mutable capability of 
baby adaptive immune system by incorporated analysis of antibody somatic hypermutation and 
antibody clonal lineage structures. We also used MIDCIRS to measure Follicular helper T cells 
(Tfhs) directly obtained from untreated HIV patients’ lymph nodes and found evidence for intact 
antigen-driven clonal expansion of Tfh cells and selective utilization of specific 
complementarity-determining region 3 (CDR3) motifs during chronic HIV infection. Both 
studies demonstrated MIDCIRS is useful for studying antigen driven immune response. 
MIDCIRS is potentially to be used in other repertoire analysis to help immunologists understand 
various types of immune response.  
 We developed another tool, named LiMPETs, to find significant motifs within TCR 
CDR3 region for different antigen specificity. The goal of LiMPETs is to find set of motifs 
significant enriched within the sequence of certain antigen specific TCR group and we 
demonstrated these motifs are generalizable to novel TCRs. We also demonstrated LiMPETs’ 
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advantage by comparing with existing tool on both public and in-house data. Due to the available 
data right now, we only focused on CD8+ TCR beta chain CDR3 region. Although previous 
research demonstrated this region is the most important, determining of TCR antigen specificity 
includes all the structures at the TCR-pMHC interface (i.e., CDR1a, CDR2a, CDR3a, CDR1b, 
CDR2b, CDR3b, peptide and helix regions of MHC), by considering only a small fraction at the 
interface limits the accuracy and coverage. One reason that we only focus on beta chain is 
because current accumulated data are most beta chain, with no information about its paired alpha 
chains. However, people are developing methods which can measure TCR alpha and beta chain 
simultaneously with its antigen specificity. With more and more paired-data available, we are 
hoping to extend the framework and increase LiMPETs’ coverage. Also, current version of 
LiMPETs only considers binary variables, by relaxing them to continuous variables (e.g., adding 













4Table S1. Metrics of sequencing results with different RNA input 






























402975 254228 63.09 10171 4579 0.11 0.32 24 0.24 
20,000Tn 
_30%RNA 
877556 698961 79.65 18670 7253 0.34 0.42 39 0.21 
20,000Tn 
_50%RNA 
1188083 984951 82.90 18367 7495 0.32 0.70 30 0.16 
100,000Tn 
_10%RNA 
922615 766441 83.07 36949 17632 0.28 0.33 89 0.24 
100,000Tn 
_30%RNA 
2409732 2173270 90.19 72257 30428 0.70 1.58 245 0.34 
100,000Tn 
_50%RNA 
1744861 1566048 89.75 55058 27280 0.52 0.99 171 0.31 
200,000Tn 
_10%RNA 
1000937 788947 78.82 61525 34097 0.41 0.86 166 0.27 
200,000Tn 
_30%RNA 
4224183 3902130 92.38 173224 66990 1.57 5.44 498 0.29 
200,000Tn 
_50%RNA 
3147293 2889513 91.81 154666 67607 1.28 2.64 628 0.41 
1,000,000Tn 
_10%RNA 
7695858 6975703 90.64 514916 237331 3.19 16.14 1430 0.28 
1,000,000Tn 
_30%RNA 
9439612 8719649 92.37 942010 382743 5.18 17.02 2387 0.25 
1,000,000Tn 
_50%RNA 
17021339 15979187 93.88 1606258 487295 8.52 47.45 4468 0.28 





39Figure S1: Comparison of diversity coverage between MIDCIRS and MIGEC pipelines on 












5Table S2: TCR repertoire sequencing cell and transcript counts. 
  Naive Memory GC Tfh 
Subject Cells TCR transcripts Cells TCR transcripts Cells TCR transcripts 
H2 10,000 14,420 10,000 6,315 15,000 33,904 
H3 10,000 6,750 10,000 8,945 10,000 7,954 
H8 10,000 13,225 10,000 5,992 10,000 26,374 
H10 10,000 4,314 10,000 9,033 1,464 2,498 
H14 10,000 5,822 10,000 6,254 10,000 11,197 
H17 10,000 18,376 10,000 6,533 10,995 37,129 
H21 10,000 10,404 10,000 7,503 10,227 23,673 











6Table S3: TCRβ Sequencing Primers. Red Ns indicate 12N random molecular identified 







Primer Target Sequence PCR Step
TCRb Constant ACA CTC TTT CCC TAC ACG ACG CTC TTC CGA TCT NNN NNN NNN NNN GAC CTC GGG TGG GAA CAC Reverse Transcription
TRBV1 GAC GTG TGC TCT TCC GAT CTC TGA CAG CTC TCG CTT ATA CCT TCA
TRBV2 GAC GTG TGC TCT TCC GAT CTG CCT GAT GGA TCA AAT TTC ACT CTG
TRBV3 GAC GTG TGC TCT TCC GAT CTA ATG AAA CAG TTC CAA ATC GMT TCT
TRBV4 GAC GTG TGC TCT TCC GAT CTC CAA GTC GCT TCT CAC CTG AAT
TRBV5-1 GAC GTG TGC TCT TCC GAT CTC GCC AGT TCT CTA ACT CTC GCT CT
TRBV5-2 GAC GTG TGC TCT TCC GAT CTT TAC TGA GTC AAA CAC GGA GCT AGG
TRBV5-3 GAC GTG TGC TCT TCC GAT CTC TCT GAG ATG AAT GTG AGT GCC TTG
TRBV5-4/5/6/7/8 GAC GTG TGC TCT TCC GAT CTC TGA GCT GAA TGT GAA CGC CTT G
TRBV6-1 GAC GTG TGC TCT TCC GAT CTT CTC CAG ATT AAA CAA ACG GGA GTT
TRBV6-2/3 GAC GTG TGC TCT TCC GAT CTC TGA TGG CTA CAA TGT CTC CAG ATT
TRBV6-4 GAC GTG TGC TCT TCC GAT CTA GTG TCT CCA GAG CAA ACA CAG ATG
TRBV6-5/6/7 GAC GTG TGC TCT TCC GAT CTG TCT CCA GAT CAA MCA CAG AGG ATT
TRBV6-8/9 GAC GTG TGC TCT TCC GAT CTA AAC ACA GAG GAT TTC CCR CTC AG
TRBV7-1 GAC GTG TGC TCT TCC GAT CTG TCT GAG GGA TCC ATC TCC ACT C
TRBV7-2 GAC GTG TGC TCT TCC GAT CTT CGC TTC TCT GCA GAG AGG ACT GG
TRBV7-3 GAC GTG TGC TCT TCC GAT CTC TGA GGG ATC CGT CTC TAC TCT GAA
TRBV7-4/8 GAC GTG TGC TCT TCC GAT CTC TGA GRG ATC CGT CTC CAC TCT G
TRBV7-5 GAC GTG TGC TCT TCC GAT CTG GTC TGA GGA TCT TTC TCC ACC T
TRBV7-6/7 GAC GTG TGC TCT TCC GAT CTG AGG GAT CCA TCT CCA CTC TGA C
TRBV7-9 GAC GTG TGC TCT TCC GAT CTC TGC AGA GAG GCC TAA GGG ATC T
TRBV8-1 GAC GTG TGC TCT TCC GAT CTA AGC TCA AGC ATT TTC CCT CAA C
TRBV8-2 GAC GTG TGC TCT TCC GAT CTA TGT CAC AGA GGG GTA CTG TGT TTC
TRBV9 GAC GTG TGC TCT TCC GAT CTA CAG TTC CCT GAC TTG CAC TCT G
TRBV10-1/3 GAC GTG TGC TCT TCC GAT CTA CAA AGG AGA AGT CTC AGA TGG CTA
TRBV10-2 GAC GTG TGC TCT TCC GAT CTT GTC TCC AGA TCC AAG ACA GAG AA
TRBV11 GAC GTG TGC TCT TCC GAT CTC TGC AGA GAG GCT CAA AGG AGT AG
TRBV12-1/2 GAC GTG TGC TCT TCC GAT CTA TCA TTC TCY ACT CTG AGG ATC CAR
TRVB12-3/4/5 GAC GTG TGC TCT TCC GAT CTA CTC TGA RGA TCC AGC CCT CAG AAC
TRBV13 GAC GTG TGC TCT TCC GAT CTC AGC TCA ACA GTT CAG TGA CTA TCA T
TRBV14 GAC GTG TGC TCT TCC GAT CTG AAA GGA CTG GAG GGA CGT ATT CTA
TRBV15 GAC GTG TGC TCT TCC GAT CTG CCG AAC ACT TCT TTC TGC TTT CT
TRBV16 GAC GTG TGC TCT TCC GAT CTA TTT TCA GCT AAG TGC CTC CCA AAT
TRBV17 GAC GTG TGC TCT TCC GAT CTC ACA GCT GAA AGA CCT AAC GGA AC
TRBV18 GAC GTG TGC TCT TCC GAT CTA TTT TCT GCT GAA TTT CCC AAA GAG
TRBV19 GAC GTG TGC TCT TCC GAT CTG TCT CTC GGG AGA AGA AGG AAT C
TRBV20-1 GAC GTG TGC TCT TCC GAT CTG ACA AGT TTC TCA TCA ACC ATG CAA
TRBV21-1 GAC GTG TGC TCT TCC GAT CTC AAT GCT CCA AAA ACT CAT CCT GT
TRBV22-1 GAC GTG TGC TCT TCC GAT CTA GGA GAA GGG GCT ATT TCT TCT CAG
TRBV23-1 GAC GTG TGC TCT TCC GAT CTA TTC TCA TCT CAA TGC CCC AAG AAC
TRBV24-1 GAC GTG TGC TCT TCC GAT CTG ACA GGC ACA GGC TAA ATT CTC C
TRBV25-1 GAC GTG TGC TCT TCC GAT CTA GTC TCC AGA ATA AGG ACG GAG CAT
TRBV26 GAC GTG TGC TCT TCC GAT CTC TCT GAG GGG TAT CAT GTT TCT TGA
TRBV27 GAC GTG TGC TCT TCC GAT CTC AAA GTC TCT CGA AAA GAG AAG AGG A
TRBV28 GAC GTG TGC TCT TCC GAT CTA AGA AGG AGC GCT TCT CCC TGA TT
TRBV29-1 GAC GTG TGC TCT TCC GAT CTC GCC CAA ACC TAA CAT TCT CAA
TRBV30 GAC GTG TGC TCT TCC GAT CTC CAG AAT CTC TCA GCC TCC AGA C
ILLUPE1adaptor_short ACA CTC TTT CCC TAC ACG AC 1st PCR, reverse
ILLUPE2adaptor_full CAA GCA GAA GAC GGC ATA CGA GAT AA NNN NNN GTG ACT GGA GTT CAG ACG TG 2nd PCR, forward




7Table S4: Gag and HA TCR sequence reference panel. 
Subject Specificity V allele J allele CDR3 Phenotype 
H2 Gag TRBV4-3*01 TRBJ1-4*01 CASSQDTRVTNEKLFF GC TFH 
H2 Gag TRBV19*01 TRBJ2-3*01 CASSLAGGLDTQYF GC TFH 
H2 Gag TRBV20-1*01 TRBJ2-4*01 CSARDYARGGGGNIQYF GC TFH 
H2 Gag TRBV7-2*01 TRBJ1-1*01 CASSLAQYTEAFF GC TFH 
H2 Gag TRBV12-3*01 TRBJ1-2*01 CASSLGQGAAGYTF GC TFH 
H2 Gag TRBV4-3*01 TRBJ2-3*01 CASSQDQRAETDTQYF GC TFH 
H2 Gag TRBV4-3*01 TRBJ1-4*01 CASSQAMGDNEKLFF GC TFH 
H2 Gag TRBV27*01 TRBJ1-5*01 CASSLRRNQPQHF Memory 
H8 HA TRBV20-1*01 TRBJ1-5*01 CSARRGADQPQHF GC TFH 
H8 HA TRBV4-3*01 TRBJ2-5*01 CASSQAGVPGTQYF GC TFH 
H14 HA TRBV18*01 TRBJ2-2*01 CASSPDRTATGELFF Memory 
H17 Gag TRBV28*01 TRBJ1-4*01 CASSRIGQGGHEKLFF GC TFH 
H17 HA TRBV12-3*01 TRBJ2-2*01 CASSLNGVTGELFF GC TFH 
H17 HA TRBV5-4*01 TRBJ2-3*01 CASSLWTGGADTQYF GC TFH 
H17 HA TRBV7-3*01 TRBJ1-5*01 CAILEGGPGQPQHF GC TFH 
H17 HA TRBV30*01 TRBJ2-1*01 CAGRGPSGSNEQFF GC TFH 
H17 HA TRBV12-3*01 TRBJ1-5*01 CASSLGQGVGQPQHF GC TFH 
H17 HA TRBV20-1*01 TRBJ2-1*01 CSARGELAEQESYNEQFF GC TFH 
H17 Gag TRBV11-3*01 TRBJ2-1*01 CASSRPLANEQFF GC TFH 
H17 Gag TRBV28*01 TRBJ1-4*01 CASSRIGQGGHEKLFF Memory 
H17 HA TRBV7-3*01 TRBJ1-5*01 CAILEGGPGQPQHF Memory 
H17 HA TRBV7-9*01 TRBJ2-5*01 CASSLAGEETQYF Naive 
H21 Gag TRBV5-4*01 TRBJ1-4*01 CASSPGEGLATNEKLFF GC TFH 
H21 Gag TRBV28*01 TRBJ1-5*01 CASSLSRDQPQHF GC TFH 
H21 Gag TRBV20-1*01 TRBJ2-7*01 CSARDGGVHEQYF GC TFH 
H21 Gag TRBV6-2*01 TRBJ1-5*01 CASTKEGQPQHL GC TFH 
H21 Gag TRBV28*01 TRBJ2-7*01 CASRPGQEAYEQYF GC TFH 
H21 Gag TRBV20-1*01 TRBJ2-2*01 CSARGLGRGIESGELFF GC TFH 
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H21 Gag TRBV7-2*01 TRBJ2-3*01 CASSPEARGPRTDTQYF GC TFH 
H21 HA TRBV29-1*01 TRBJ1-2*01 CSVDRAGTNYGYTF GC TFH 
H24 Gag TRBV6-1*01 TRBJ1-5*01 CASSEARNRGLGQPQHF GC TFH 
H24 Gag TRBV20-1*01 TRBJ1-1*01 CSARDRGRATEAFF GC TFH 













































11Table S8. Data selected for training in VDJdb  
 








ID host_species antigen_species TCRab MHC MHC.A MHC.B Epitope number_of_unique_CDR3s 
2 HomoSapiens CMV TRB MHCI HLA-A*02 B2M NLVPMVATV 4223 
3 HomoSapiens CMV TRB MHCI HLA-B*07 B2M TPRVTGGGAM 156 
4 HomoSapiens CMV TRB MHCI HLA-A*01 B2M VTEHDTLLY 199 
5 HomoSapiens DENV1 TRB MHCI HLA-A*11 B2M GTSGSPIVNR 165 
6 HomoSapiens DENV3/4 TRB MHCI HLA-A*11 B2M GTSGSPIINR 158 
8 HomoSapiens EBV TRB MHCI HLA-A*02 B2M GLCTLVAML 846 
9 HomoSapiens EBV TRB MHCI HLA-B*08 B2M RAKFKQLL 172 
12 HomoSapiens HCV TRB MHCI HLA-A*01 B2M ATDALMTGY 165 
13 HomoSapiens HCV TRB MHCI HLA-A*02 B2M CINGVCWTV 124 
15 HomoSapiens HIV-1 TRB MHCI HLA-B*57 B2M KAFSPEVIPMF 171 
16 HomoSapiens HIV-1 TRB MHCI HLA-B*27 B2M KRWIILGLNK 280 
25 HomoSapiens InfluenzaA TRB MHCI HLA-A*02 B2M GILGFVFTL 2541 
26 HomoSapiens InfluenzaA TRB MHCI HLA-B*07 B2M LPRRSGAAGA 159 





12Table S9. Data selected for testing within VDJdb 
testID host_species antigen_species TCRab MHC MHC.A MHC.B Epitope Reference 
1 HomoSapiens CMV TRB MHCI HLA\-A\*02 B2M NLVPMVATV PMID:19017975 
2 HomoSapiens CMV TRB MHCI HLA\-A\*02 B2M NLVPMVATV PMID:28423320 
4 HomoSapiens EBV TRB MHCI HLA\-A\*02 B2M GLCTLVAML PMID:19017975 
5 HomoSapiens EBV TRB MHCI HLA\-A\*02 B2M GLCTLVAML PMID:28636589 
6 HomoSapiens EBV TRB MHCI HLA\-A\*02 B2M GLCTLVAML PMID:28636592 
9 HomoSapiens EBV TRB MHCI HLA\-B\*08 B2M RAKFKQLL PMID:24512815 
12 HomoSapiens InfluenzaA TRB MHCI HLA\-A\*02 B2M GILGFVFTL PMID:28423320 
13 HomoSapiens InfluenzaA TRB MHCI HLA\-A\*02 B2M GILGFVFTL PMID:28636589 
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